411 results on '"Silva DM"'
Search Results
2. RELATO DE CASO: AVALIAÇÃO DOS AGRAVOS BUCAIS E SISTÊMICOS EM PACIENTE PEDIÁTRICO COM LEUCEMIA LINFOIDE AGUDA
- Author
-
Silva, DM, Sampaio, GM, Alexandre, CN, Libório-Kimura, TN, and Fernandes, OCC
- Published
- 2024
- Full Text
- View/download PDF
3. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- Author
-
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR, Josse RG, Califf RM, Goldstein BJ, Shapiro DR, Silverman R, Bethel A, Green J, Hayden S, Hannan K, Quintero K, Rorick T, Berdan L, Leloudis D, Califf S, Wilson M, McFarron D, Trollinger K, Pesarchick J, Eskenazi L, Campbell C, Townes O, Tolsma D, Keenan J, Milton J, Athwal R, Darbyshire J, Doran Z, Kennedy I, Gregory V, Lokhnygina Y, Prather K, Wolfley A, Usman M, Tajjar A, Gray R, Pfeffer MA, Gerstein HC, Groop L, McMurray JJ, Pocock SJ, Clayton T, Sinay I, Brieger D, Stranks S, Scheen A, Lopes R, Tankova T, Hramiak I, Grado CR, Wenying Y, Ge J, Aschner P, Skrha J, Ambos A, Strandberg T, Travert F, Hanefeld M, Riefflin A, Chan JC, Ofner P, Reddy NK, Christopher J, Mathur A, Arambam P, Mittal S, Manchanda M, Wainstein J, Ambrosio G, Pirags V, Jakuboniene N, Mohamed M, Scott R, White H, Cornel J, Halvorsen S, Tykarski A, Veresiu IA, Dreval AV, Misinkova I, Tai E, Krahulec B, Distiller L, Park Y, Rovira A, Alversson M, Chuang LM, Delibasi T, Adler A, Rodbard HW, Marre M, Goff D, Chacra A, DeVore A, Beaven A, Shah B, Hirsch B, Batch B, Bushnell C, Patel C, Melloni C, Henshaw C, Kong D, Bernecki G, Tillman H, Kang HJ, Hawes J, Strickler J, Piccini J, Wilder J, Alexander K, Mahaffey K, Patel K, Hyland K, Newby K, Jackson L, Cooper L, Armaganijan L, Szczeh L, Koshizaka M, Roe M, Morse M, Guimaraes P, Hess P, Tricoci P, Mehta R, Mathews R, Kociol R, Harrison R, Mentz R, Pokorney S, Leblanc T, Lazzarini V, Eapen Z, Truffa A, Fosbol E, Brito F, Katz M, Bahit M, Santos M, Barros P, Bernardez S, Alvarisqueta AF, Arias P, Cagide AL, Calella PR, Cantero MC, Canella JP, Cipullo MA, de Loredo L, Gelersztein ES, Gorban de Lapertosa SB, Klyver MI, Maffei LE, Maldonado N, Oviedo AI, Piskorz DL, Ridruejo MC, Saavedra SS, Sessa HA, Sinay IR, Sposetti GD, Ulla MR, Vico ML, Waitman JN, Binnekamp M, Carroll P, Cheung W, Colman P, Davis T, De Looze F, dEmden M, Fulcher G, Gerstman M, Hamilton A, Lehman S, Moses R, Proietto J, Roberts A, Shaw J, Simpson R, Sinha A, Tan Y, Topliss D, Vora P, Waites J, Crenier L, Descamps O, Keymeulen B, Mathieu C, Nobels F, Van den Bruel A, Van Gaal L, Borges JL, Costa e Forti A, Eliaschewitz FG, Felício JS, Griz LH, Hissa MN, Leite S, Panarotto D, Pimentel Filho P, Rassi N, Saraiva JK, Sgarbi JA, Silva RP, Tambascia M, Weber Silva DM, Bobeva R, Bostandzhieva R, Cinlikov I, Georgieva M, Iliev D, Ilieva E, Kovacheva S, Liubenova L, Nikitov Z, SHeinikova G, Slavcheva A, Spasova V, Temelkova-Kurktschiev T, Velichka D, Yakov A, Carpentier A, Chiasson JL, Constance C, Dumas R, Filteau P, Garceau C, Huynh T, Kaiser S, Kornder J, Leiter L, Mereu L, Miller D, Pandey S, Punthakee Z, Rabasa-Lhoret R, Robitaille Y, Saunders K, Sigal R, Sigalas J, Vizel S, Weisnagel S, Woo V, Yale JF, Yared K, Zinman B, Bunster Balocchi LB, Escobar Cerda EE, Garces Flores EE, Lanas Zanetti FT, Larrazabal Miranda Adel P, Morales Alvarado JM, Olivares Cañon CM, Potthoff Cárdenas SH, Raffo Grado CA, Rodriguez Venegas ME, Saavedra Gajardo VA, Westerberg Maldonado BH, Chen LL, Dong J, Guo X, Li QM, Shi B, Tang XL, Yang T, Yang WY, Zheng SX, Aschner Montoya P, Botero Lopez R, Coronel Arroyo JA, Cure CA, Gómez Medina AM, Molina DI, Perez Amador GA, Reyes Rincon A, Urina Triana MA, Valenzuela Rincon A, Vélez Pelaez S, Yupanqui Lozno H, Brabec T, Brychta T, Hasalova Zapletalova J, Havelkova J, Hejnicova K, Hola O, Hornackova M, Hrdina T, Kafkova D, Kellnerova I, Krystl T, Kutejova V, Mikulkova I, Nevrla J, Pantlikova C, Petr M, Racicka E, Sarbochova R, Smolenakova K, Turcinek R, Urbancova K, Vejvodova J, Vondrakova M, Zachoval R, Alt I, Kaasik Ü, Kiiroja K, Lanno R, Märtsin K, Past M, Vides H, Viitas L, Kantola I, Nieminen S, Perhonen M, Strand J, Valle T, Clergeot A, Couffinhal T, Courreges JP, Gouet D, Moulin P, Ziegler O, Badenhoop K, Behnke T, Bender G, Braun M, Dshabrailov J, Hamann A, Himpel-Boenninghoff A, Kamke W, Kasperk C, Luedemann J, Mayr P, Merkel M, Oerter EM, Ohlow MA, Ott P, Overhoff U, Paschen B, Remppis R, Rose L, Schumm-Draeger PM, Segiet T, Strotmann HJ, Stuchlik G, Stürmer W, Thinesse-Mallwitz M, Tytko A, Wendisch U, Wurziger J, Ho AY, Kam G, Kong AP, Lam YY, Lau EY, Lee S, Siu SC, Tomlinson B, Tsang CC, Yeung VT, Dezső E, Dudás M, Földesi I, Fülöp T, Késmárki N, Koranyi L, Nagy K, Oroszlán T, Pécsvárady Z, Ples Z, Taller A, Agarwal P, Ambulkar S, Aravind S, Balaji V, Kalra S, Kesavadev J, Kudalkar H, Kumar A, Misra A, Mithal A, Mohan V, Pitale S, Ramu M, Reddy N, Shah S, Shamanna P, Sharda A, Sharma A, Shunmugavelu M, Srikanta S, Suryaprakash G, Abramov G, Adawi F, Bashkin A, Darawsha M, Fuchs S, Harman-Boehm I, Hayek T, Jaffe A, Knobler H, Minuchin O, Mosseri M, Shechter M, Shimon I, Stern N, Tsur A, Vishlitzky V, Alfonsi F, Cavalot F, Del Vecchio L, Frisinghelli A, Gambardella S, Lauro D, Lembo G, Leotta S, Mondillo S, Novo S, Pedrinelli R, Piatti P, Salvioni A, Tritto I, Zavaroni DZ, Ahn KJ, Choi KM, Chung C, Han SJ, Kim DM, Kim IJ, Kim MH, Lee IK, Nam M, Park IeB, Park KS, Park TS, Rhee EJ, Yoo SJ, Andersone I, Balode A, Eglite R, Gersamija A, Kakurina N, Jegere B, Leitane I, Pastare S, Stalte V, Teterovska D, Baltramonaitiene K, Barsiene L, Ceponis J, Lasiene J, Levinger A, Sirutaviciene A, Sulskiene M, Urbanaviciene L, Valius L, Varanauskiene E, Velickiene D, Mahendran KA, Abu Hassan MR, Aziz NA, Hussein Z, Ismail IS, Kamaruddin NA, Nordin Z, Nayar SK, Ramanathan GR, Sothiratnam R, Beijerbacht H, Breedveld R, Cornel JH, Den Hartog F, Hermans W, Kietselaer B, Kooy A, Lenderink T, Nierop P, Remmen J, Rojas Lingan G, Ronner E, Van der Heijden R, Van Hessen M, van Kempen W, Voors-Pette C, Westendorp I, Baker J, Benatar J, Cutfield R, Krebs J, Leikis R, Lunt H, Manning P, Williams M, Birkeland K, Claudi T, Istad H, Karlsson T, Ossum Gronert J, Arciszewska M, Artemiuk E, Blach E, Blicharski T, Cypryk K, Dabrowska M, Górny G, Górska M, Jakubowska I, Jazwinska-Tarnawska E, Karczmarczyk A, Kitowska-Koterla J, Koltowski L, Krzyzagorska E, Pasternak D, Pentela-Nowicka J, Piesiewicz W, Przekwas-Jaruchowska M, Rajzer M, Salamon-Ferenc A, Sawicki A, Skowron T, Śmiałowski A, Albota A, Alexandru C, Crisan C, Dumitrescu A, Ferariu IE, Lupusoru DA, Munteanu M, Negru D, Nicolau A, Pintiliei E, Popescu A, Serban G, Voitec M, Babenko A, Barbarash O, Bondar I, Chizhov P, Demin A, Dora S, Dreval A, Ershova O, Gratsiansky N, Ketova G, Kotelnikov M, Levashov S, Morugova T, Mustafina S, Pekarskiy S, Raskina T, Rechkova E, Samoylova Y, Sazonova O, Sherenkov A, Shilkina N, Stetsyuk O, Tretyakova T, Turova E, Valeeva F, Zadionchenko V, Dalan R, Tan RS, Tay L, Buganova I, Fabry J, Jan C, Toserova E, Zak R, Zimanova J, Badat A, Bester F, Burgess L, De Jong D, Ellis G, Fouche L, Govender P, Govind U, Naidoo V, Nieuwoudt G, Nortje H, Rheeder P, Robertson L, Siddique N, Stapelberg AM, Trinder Y, Van Der Merwe A, Van Zyl L, Viljoen M, Wilhase A, Botella M, Civeira Murillo F, de Teresa L, Del Cañizo FJ, Extremera BG, Gimeno EJ, Martin-Hidalgo A, Morales C, Nubiola A, Tinahones Madueño F, Tranche S, Trescolí Serrano C, Alvarsson M, Eizyk E, Gillblad A, Johansson P, Löndahl M, Ohlsson-Önerud Å, Rautio A, Sundström U, Torstensson I, Chen JF, Chou CW, Ho LT, Hsieh IC, Huang BH, Huang CL, Huang CN, Lai WT, Lo PH, Pei D, Sheu WH, Wang SY, Araz M, Bakiner O, Comlekci A, Guler S, Sahin I, Sarac F, Tarkun I, Ukinc K, Yilmaz M, Abdulhakim E, Abraham P, Adamson K, Blagden M, Bundy C, Daly M, Davies M, Deshpande M, Gillings S, Harvey P, Horvathova V, Hristova D, Jaap A, Johnson A, Jones H, Kerrane J, Kilvert A, Ko T, Kumar J, Lindsay R, Litchfield J, McCrimmon R, McKnight J, Millward B, Oyesile B, Purewal T, Ravikumar C, Robinson A, Sathyapalan T, Simpson H, Thomas H, Turner W, Weaver J, Wilding J, Wiles P, Adkins K, Akpunonu B, Albu J, Anagnostis G, Anastasi L, Argoud G, Aroda V, Azizad M, Banerji MA, Bartkowiak A Jr, Bays H, Behn P, Bergenstal R, Bhargava A, Bias D, Bolster E, Buchanan P, Busch R, Chadha C, Chang M, Cheng C, Cohen A, Cohen J, Cole B, Connery L, Cooperman M, Cushman W, DAgostino R, Dayamani P, De Lemos J, De Meireles M, Dean J, DeHart D, Detweiler R, Donovan D, Dugano-Daphnis P, Dulin M, Dunn F, Eaton C, Erickson B, Estevez R, Feinglos M, Fonseca V, Force R, Forker A, Fox D, Gabriel J, Garcia R, Garvey T, Gaudiani L, Getaneh A, Goldberg A, Goldman S, Hairston K, Harris R, Haught W, Hidalgo H Jr, Higgins A, Houchin V, Ison R, Jacobs G, Jaffrani N, Jafry B, Kapsner P, Kaye W, Labroo A, Levinson L, Lewis S, Lillestol M, Luttrell L, Madu I, McNeill R, Merrick B, Metzger F, Nadar V, Nagelberg S, Nash S, Oparil S, Osei K, Papademetriou V, Patel N, Pedley C, Prentiss A, Radbill M, Raisinghani A, Rassouli N, Reddy R, Rees P, Rendell M, Robbins D, Rodbard H, Rohlf J, Roseman H, Rudolph L, Sadler L, Schnall A, Schramm R, Schubart U, Seneviratne T, Shanik M, Snyder H, Sorli C, Stich M, Sweeney ME, Tsao J, Ukwade P, Viswanath D, Vo A, Vogel C, Voyce S, Weintraub H, White J, Wood M, Wu P, Wysham C, Zimmerman R, Pathology/molecular and cellular medicine, Diabetes Pathology & Therapy, and Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR, Holman RR, Peterson ED, Holman RR, Peterson ED, Armstrong PW, Buse JB, Josse RG, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Engel SS, Califf RM, Goldstein BJ, Shapiro DR, Silverman R, Bethel A, Green J, Hayden S, Hannan K, Quintero K, Rorick T, Berdan L, Leloudis D, Califf S, Wilson M, McFarron D, Trollinger K, Pesarchick J, Eskenazi L, Campbell C, Townes O, Tolsma D, Keenan J, Milton J, Athwal R, Darbyshire J, Doran Z, Kennedy I, Gregory V, Garg J, Lokhnygina Y, Prather K, Wolfley A, Usman M, Tajjar A, Gray R, Pfeffer MA, Gerstein HC, Groop L, McMurray JJ, Pocock SJ, Clayton T, Sinay I, Brieger D, Stranks S, Scheen A, Lopes R, Tankova T, Hramiak I, Grado CR, Wenying Y, Ge J, Aschner P, Skrha J, Ambos A, Strandberg T, Travert F, Hanefeld M, Riefflin A, Chan JC, Ofner P, Reddy NK, Christopher J, Mathur A, Arambam P, Mittal S, Manchanda M, Wainstein J, Ambrosio G, Pirags V, Jakuboniene N, Mohamed M, Scott R, White H, Cornel J, Halvorsen S, Tykarski A, Veresiu IA, Dreval AV, Misinkova I, Tai E, Krahulec B, Distiller L, Park Y, Rovira A, Alversson M, Chuang LM, Delibasi T, Adler A, Rodbard HW, Marre M, Goff D, Chacra A, DeVore A, Beaven A, Shah B, Hirsch B, Batch B, Bushnell C, Patel C, Melloni C, Henshaw C, Kong D, McFarron D, Bernecki G, Tillman H, Kang HJ, Green J, Hawes J, Strickler J, Piccini J, Wilder J, Alexander K, Mahaffey K, Patel K, Hyland K, Newby K, Jackson L, Cooper L, Armaganijan L, Szczeh L, Koshizaka M, Roe M, Morse M, Guimaraes P, Hess P, Tricoci P, Mehta R, Lopes R, Mathews R, Kociol R, Harrison R, Mentz R, Pokorney S, Leblanc T, Lazzarini V, Eapen Z, Truffa A, Fosbol E, Brito F, Katz M, Bahit M, Santos M, Barros P, Bernardez S, Alvarisqueta AF, Arias P, Cagide AL, Calella PR, Cantero MC, Canella JP, Cipullo MA, de Loredo L, Gelersztein ES, Gorban de Lapertosa SB, Klyver MI, Maffei LE, Maldonado N, Oviedo AI, Piskorz DL, Ridruejo MC, Saavedra SS, Sessa HA, Sinay IR, Sposetti GD, Ulla MR, Vico ML, Waitman JN, Binnekamp M, Carroll P, Cheung W, Colman P, Davis T, De Looze F, dEmden M, Fulcher G, Gerstman M, Hamilton A, Lehman S, Moses R, Proietto J, Roberts A, Shaw J, Simpson R, Sinha A, Stranks S, Tan Y, Topliss D, Vora P, Waites J, Crenier L, Descamps O, Keymeulen B, Mathieu C, Nobels F, Scheen A, Van den Bruel A, Van Gaal L, Borges JL, Costa e Forti A, Eliaschewitz FG, Felício JS, Griz LH, Hissa MN, Leite S, Panarotto D, Pimentel Filho P, Rassi N, Saraiva JK, Sgarbi JA, Silva RP, Tambascia M, Weber Silva DM, Bobeva R, Bostandzhieva R, Cinlikov I, Georgieva M, Iliev D, Ilieva E, Kovacheva S, Liubenova L, Nikitov Z, SHeinikova G, Slavcheva A, Spasova V, Tankova T, Temelkova-Kurktschiev T, Velichka D, Yakov A, Carpentier A, Chiasson JL, Constance C, Dumas R, Filteau P, Garceau C, Hramiak I, Huynh T, Kaiser S, Kornder J, Leiter L, Mereu L, Miller D, Pandey S, Punthakee Z, Rabasa-Lhoret R, Robitaille Y, Saunders K, Sigal R, Sigalas J, Vizel S, Weisnagel S, Woo V, Yale JF, Yared K, Zinman B, Bunster Balocchi LB, Escobar Cerda EE, Garces Flores EE, Lanas Zanetti FT, Larrazabal Miranda Adel P, Morales Alvarado JM, Olivares Cañon CM, Potthoff Cárdenas SH, Raffo Grado CA, Rodriguez Venegas ME, Saavedra Gajardo VA, Westerberg Maldonado BH, Chen LL, Dong J, Guo X, Li QM, Shi B, Tang XL, Yang T, Yang WY, Zheng SX, Aschner Montoya P, Botero Lopez R, Coronel Arroyo JA, Cure CA, Gómez Medina AM, Molina DI, Perez Amador GA, Reyes Rincon A, Urina Triana MA, Valenzuela Rincon A, Vélez Pelaez S, Yupanqui Lozno H, Brabec T, Brychta T, Hasalova Zapletalova J, Havelkova J, Hejnicova K, Hola O, Hornackova M, Hrdina T, Kafkova D, Kellnerova I, Krystl T, Kutejova V, Mikulkova I, Nevrla J, Pantlikova C, Petr M, Racicka E, Sarbochova R, Skrha J, Smolenakova K, Turcinek R, Urbancova K, Vejvodova J, Vondrakova M, Zachoval R, Alt I, Ambos A, Kaasik Ü, Kiiroja K, Lanno R, Märtsin K, Past M, Vides H, Viitas L, Kantola I, Nieminen S, Perhonen M, Strand J, Strandberg T, Valle T, Clergeot A, Couffinhal T, Courreges JP, Gouet D, Moulin P, Travert F, Ziegler O, Badenhoop K, Behnke T, Bender G, Braun M, Dshabrailov J, Hamann A, Hanefeld M, Himpel-Boenninghoff A, Kamke W, Kasperk C, Luedemann J, Mayr P, Merkel M, Oerter EM, Ohlow MA, Ott P, Overhoff U, Paschen B, Remppis R, Riefflin A, Rose L, Schumm-Draeger PM, Segiet T, Strotmann HJ, Stuchlik G, Stürmer W, Thinesse-Mallwitz M, Tytko A, Wendisch U, Wurziger J, Ho AY, Kam G, Kong AP, Lam YY, Lau EY, Lee S, Siu SC, Tomlinson B, Tsang CC, Yeung VT, Dezső E, Dudás M, Földesi I, Fülöp T, Késmárki N, Koranyi L, Nagy K, Ofner P, Oroszlán T, Pécsvárady Z, Ples Z, Taller A, Agarwal P, Ambulkar S, Aravind S, Balaji V, Christopher J, Kalra S, Kesavadev J, Kudalkar H, Kumar A, Misra A, Mithal A, Mohan V, Pitale S, Ramu M, Reddy N, Shah S, Shamanna P, Sharda A, Sharma A, Shunmugavelu M, Srikanta S, Suryaprakash G, Abramov G, Adawi F, Bashkin A, Darawsha M, Fuchs S, Harman-Boehm I, Hayek T, Jaffe A, Knobler H, Minuchin O, Mosseri M, Shechter M, Shimon I, Stern N, Tsur A, Vishlitzky V, Wainstein J, Alfonsi F, Cavalot F, Del Vecchio L, Frisinghelli A, Gambardella S, Lauro D, Lembo G, Leotta S, Mondillo S, Novo S, Pedrinelli R, Piatti P, Salvioni A, Tritto I, Zavaroni DZ, Ahn KJ, Choi KM, Chung C, Han SJ, Kim DM, Kim IJ, Kim MH, Lee IK, Nam M, Park IeB, Park KS, Park TS, Park Y, Rhee EJ, Yoo SJ, Andersone I, Balode A, Eglite R, Gersamija A, Kakurina N, Jegere B, Leitane I, Pastare S, Pirags V, Stalte V, Teterovska D, Baltramonaitiene K, Barsiene L, Ceponis J, Jakuboniene N, Lasiene J, Levinger A, Sirutaviciene A, Sulskiene M, Urbanaviciene L, Valius L, Varanauskiene E, Velickiene D, Mahendran KA, Abu Hassan MR, Aziz NA, Hussein Z, Ismail IS, Kamaruddin NA, Mohamed M, Nordin Z, Nayar SK, Ramanathan GR, Sothiratnam R, Beijerbacht H, Breedveld R, Cornel JH, Den Hartog F, Hermans W, Kietselaer B, Kooy A, Lenderink T, Nierop P, Remmen J, Rojas Lingan G, Ronner E, Van der Heijden R, Van Hessen M, van Kempen W, Voors-Pette C, Westendorp I, Baker J, Benatar J, Cutfield R, Krebs J, Leikis R, Lunt H, Manning P, Scott R, Williams M, Birkeland K, Claudi T, Halvorsen S, Istad H, Karlsson T, Ossum Gronert J, Arciszewska M, Artemiuk E, Blach E, Blicharski T, Cypryk K, Dabrowska M, Górny G, Górska M, Jakubowska I, Jazwinska-Tarnawska E, Karczmarczyk A, Kitowska-Koterla J, Koltowski L, Krzyzagorska E, Pasternak D, Pentela-Nowicka J, Piesiewicz W, Przekwas-Jaruchowska M, Rajzer M, Salamon-Ferenc A, Sawicki A, Skowron T, Śmiałowski A, Tykarski A, Albota A, Alexandru C, Crisan C, Dumitrescu A, Ferariu IE, Lupusoru DA, Munteanu M, Negru D, Nicolau A, Pintiliei E, Popescu A, Serban G, Veresiu IA, Voitec M, Babenko A, Barbarash O, Bondar I, Chizhov P, Demin A, Dora S, Dreval A, Ershova O, Gratsiansky N, Ketova G, Kotelnikov M, Levashov S, Morugova T, Mustafina S, Pekarskiy S, Raskina T, Rechkova E, Samoylova Y, Sazonova O, Sherenkov A, Shilkina N, Stetsyuk O, Tretyakova T, Turova E, Valeeva F, Zadionchenko V, Dalan R, Tan RS, Tay L, Buganova I, Fabry J, Jan C, Krahulec B, Toserova E, Zak R, Zimanova J, Badat A, Bester F, Burgess L, De Jong D, Distiller L, Ellis G, Fouche L, Govender P, Govind U, Naidoo V, Nieuwoudt G, Nortje H, Rheeder P, Robertson L, Siddique N, Stapelberg AM, Trinder Y, Van Der Merwe A, Van Zyl L, Viljoen M, Wilhase A, Botella M, Civeira Murillo F, de Teresa L, Del Cañizo FJ, Extremera BG, Gimeno EJ, Martin-Hidalgo A, Morales C, Nubiola A, Rovira A, Tinahones Madueño F, Tranche S, Trescolí Serrano C, Alvarsson M, Eizyk E, Gillblad A, Johansson P, Löndahl M, Ohlsson-Önerud Å, Rautio A, Sundström U, Torstensson I, Chen JF, Chou CW, Chuang LM, Ho LT, Hsieh IC, Huang BH, Huang CL, Huang CN, Lai WT, Lo PH, Pei D, Sheu WH, Wang SY, Araz M, Bakiner O, Comlekci A, Delibasi T, Guler S, Sahin I, Sarac F, Tarkun I, Ukinc K, Yilmaz M, Abdulhakim E, Abraham P, Adamson K, Adler A, Blagden M, Bundy C, Daly M, Davies M, Deshpande M, Gillings S, Harvey P, Horvathova V, Horvathova V, Hristova D, Jaap A, Johnson A, Jones H, Kerrane J, Kilvert A, Ko T, Kumar J, Lindsay R, Litchfield J, McCrimmon R, McKnight J, Millward B, Oyesile B, Purewal T, Ravikumar C, Robinson A, Sathyapalan T, Simpson H, Thomas H, Turner W, Weaver J, Wilding J, Wiles P, Adkins K, Akpunonu B, Albu J, Anagnostis G, Anastasi L, Argoud G, Aroda V, Azizad M, Banerji MA, Bartkowiak A Jr, Bays H, Behn P, Bergenstal R, Bhargava A, Bias D, Bolster E, Buchanan P, Busch R, Chadha C, Chang M, Cheng C, Cohen A, Cohen J, Cole B, Connery L, Cooperman M, Cushman W, DAgostino R, Davies M, Dayamani P, De Lemos J, De Meireles M, Dean J, DeHart D, Detweiler R, Donovan D, Dugano-Daphnis P, Dulin M, Dunn F, Eaton C, Erickson B, Estevez R, Feinglos M, Fonseca V, Force R, Forker A, Fox D, Gabriel J, Garcia R, Garvey T, Gaudiani L, Getaneh A, Goff D, Goldberg A, Goldman S, Hairston K, Harris R, Haught W, Hidalgo H Jr, Higgins A, Houchin V, Ison R, Jacobs G, Jaffrani N, Jafry B, Kapsner P, Kaye W, Labroo A, Levinson L, Lewis S, Lillestol M, Luttrell L, Madu I, McNeill R, Merrick B, Metzger F, Nadar V, Nagelberg S, Nash S, Oparil S, Osei K, Papademetriou V, Patel N, Pedley C, Prentiss A, Radbill M, Raisinghani A, Rassouli N, Reddy R, Rees P, Rendell M, Robbins D, Rodbard H, Rohlf J, Roseman H, Rudolph L, Sadler L, Schnall A, Schramm R, Schubart U, Seneviratne T, Shanik M, Snyder H, Sorli C, Stich M, Sweeney ME, Tsao J, Ukwade P, Viswanath D, Vo A, Vogel C, Voyce S, Weintraub H, White J, Wood M, Wu P, Wysham C, Zimmerman R
- Subjects
Oral ,medicine.medical_specialty ,Heart diseases ,Glycosylated ,Administration, Oral ,heart failure ,Type 2 diabetes ,Dipeptidyl peptidase-4 inhibitor ,Kaplan-Meier Estimate ,Placebo ,Sitagliptin Phosphate ,Sitagliptin, Cardiovascular Outcomes ,chemistry.chemical_compound ,Drug Therapy ,Double-Blind Method ,Internal medicine ,Diabetes Mellitus ,medicine ,Humans ,Hypoglycemic Agents ,Glycated Hemoglobin ,Hemoglobin A, Glycosylated ,Cardiovascular Diseases ,Diabetes Mellitus, Type 2 ,Drug Therapy, Combination ,Follow-Up Studies ,Heart Diseases ,Heart Failure ,Hospitalization ,Pyrazines ,Triazoles ,Medicine (all) ,business.industry ,Semaglutide ,Hemoglobin A ,General Medicine ,ta3121 ,medicine.disease ,Surgery ,Cardiovascular diseases ,chemistry ,Sitagliptin ,Administration ,Combination ,Glycated hemoglobin ,business ,Type 2 ,Alogliptin ,medicine.drug - Abstract
BACKGROUND: Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and cardiovascular disease. METHODS: In this randomized, double-blind study, we assigned 14,671 patients to add either sitagliptin or placebo to their existing therapy. Open-label use of antihyperglycemic therapy was encouraged as required, aimed at reaching individually appropriate glycemic targets in all patients. To determine whether sitagliptin was noninferior to placebo, we used a relative risk of 1.3 as the marginal upper boundary. The primary cardiovascular outcome was a composite of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina. RESULTS: During a median follow-up of 3.0 years, there was a small difference in glycated hemoglobin levels (least-squares mean difference for sitagliptin vs. placebo, -0.29 percentage points; 95% confidence interval [CI], -0.32 to-0.27). Overall, the primary outcome occurred in 839 patients in the sitagliptin group (11.4%; 4.06 per 100 person-years) and 851 patients in the placebo group (11.6%; 4.17 per 100 person-years). Sitagliptin was noninferior to placebo for the primary composite cardiovascular outcome (hazard ratio, 0.98; 95% CI, 0.88 to 1.09; P
- Published
- 2015
- Full Text
- View/download PDF
4. Centrality, rapidity and transverse momentum dependence of J/ψ suppression in Pb–Pb collisions at √sNN = 2.76 TeV
- Author
-
Piano, Stefano, Lea, Ramona, Camerini, Paolo, Luparello, Grazia, Fragiacomo, Enrico, Margagliotti, Giacomo, Rui, Rinaldo, Abelev bv, B., Adam al, J., Adamová cd, D., Aggarwal ch, M. M., Aglieri Rinella ah, G., Agnello cn, M., Agocs eb, A. G., Agostinelli z, A., Agrawal as, N., Ahammed dx, Z., Ahmad r, N., Ahmad Masoodi r, A., Ahmed o, I., Ahn bo, S. U., Ahn bo, S. A., Aimo de, I., Aiola ec, S., Ajaz o, M., Akindinov be, A., Aleksandrov ct, D., Alessandro de, B., Alexandre cv, D., Alici l, A., Alkin c, A., Alme aj, J., Alt an, T., Altini ae, V., Altinpinar q, S., Altsybeev dw, I., Alves Garcia Prado dm, C., Andrei by, C., Andronic cq, A., Anguelov cm, V., Anielski az, J., Anticˇic ́ cr, T., Antinori db, F., Antonioli cy, P., Aphecetche df, L., Appelshäuser ax, H., Arbor br, N., Arcelli z, S., Armesto p, N., Arnaldi de, R., Aronsson ec, T., Arsene u, I. C., Arslandok ax, M., Augustinus ah, A., Averbeck cq, R., Awes ce, T. C., Azmi r, M. D., Bach an, M., Badalà da, A., Baek ao, Y. W., Bagnasco de, S., Bailhache ax, R., Bairathi cl, V., Bala ck, R., Baldisseri n, A., Baltasar Dos Santos Pedrosa ah, F., Bán bf, J., Baral bh, R. C., Barbera aa, R., Barile ae, F., Barnaföldi eb, G. G., Barnby cv, L. S., Barret bq, V., Bartke dj, J., Basile z, M., Bastid bq, N., Basu dx, S., Bathen az, B., Batigne df, G., Batyunya bm, B., Batzing u, P. C., Baumann ax, C., Bearden ca, I. G., Beck ax, H., Bedda cn, C., Behera as, N. K., Belikov ba, I., Bellini z, F., Bellwied do, R., Belmont Moreno bk, E., Bencedi eb, G., Beole y, S., Berceanu by, I., Bercuci by, A., Berdnikov cf, Y., 1, Berenyi eb, D., Berger di, M. E., Bergognon df, A. A. E., Bertens bd, R. A., Berzano y, D., Betev ah, L., Bhasin ck, A., Bhati ch, A. K., Bhattacharjee ap, B., Bhom dt, J., Bianchi y, L., Bianchi bs, N., Bianchin bd, C., Bielcˇík al, J., Bielcˇíková cd, J., Bilandzic ca, A., Bjelogrlic bd, S., Blanco j, F., Blau ct, D., Blume ax, C., Bock bu, F., Boehmer di, F. V., Bogdanov bw, A., Bøggild ca, H., Bogolyubsky bb, M., Boldizsár eb, L., Bombara am, M., Book ax, J., Borel n, H., Borissov cp, A., Bornschein an, J., Bossú bl, F., Botje cb, M., Botta y, E., Böttger aw, S., Braun Munzinger cq, P., Bregant dm, M., Breitner aw, T., Broker ax, T. A., Browning co, T. A., Broz ak, M., Bruna de, E., Bruno ae, G. E., Budnikov cs, D., Buesching ax, H., Bufalino de, S., Buncic ah, P., Busch cm, O., Buthelezi bl, Z., Caffarri ab, D., Cai g, X., Caines ec, H., Caliva bd, A., Calvo Villar cw, E., Canoa Roman ah, V., Carena ah, F., Carena ah, W., Carminati ah, F., Casanova Díaz bs, A., Castillo Castellanos n, J., Casula w, E. A. R., Catanescu by, V., Cavicchioli ah, C., Ceballos Sanchez i, C., Cepila al, J., Cerello de, P., Chang dp, B., Chapeland ah, S., Charvet n, J. L., Chattopadhyay dx, S., Chattopadhyay cu, S., Cherney cg, M., Cheshkov dv, C., Cheynis dv, B., Chibante Barroso ah, V., Chinellato do, D. D., Chochula ah, P., Chojnacki ca, M., Choudhury dx, S., Christakoglou cb, P., Christensen ca, C. H., Christiansen af, P., Chujo dt, T., Chung cp, S. U., Cicalo cz, C., Cifarelli l, L., Z, Cindolo cy, F., Cleymans cj, J., Colamaria ae, F., Colella ae, D., Collu w, A., Colocci z, M., Conesa Balbastre br, G., Conesa del Valle av, Z., Connors ec, M. E., Contin x, G., Contreras k, J. G., Cormier ce, T. M., Corrales Morales y, Y., Cortese ad, P., Cortés Maldonado b, I., Cosentino bu, M. R., Costa ah, F., Crochet bq, P., Cruz Albino k, R., Cuautle bj, E., Cunqueiro bs, L., Dainese db, A., Dang g, R., Danu bi, A., Das cu, D., Das av, I., Das cu, K., Das d, S., Dash dn, A., Dash as, S., De dx, S., Delagrange df, H., 2, Deloff bx, A., Dénes eb, E., D’Erasmo ae, G., de Barros dm, G. O. V., De Caro l, A., de Cataldo cx, G., de Cuveland an, J., De Falco w, A., De Gruttola ac, D., L, De Marco de, N., De Pasquale ac, S., de Rooij bd, R., Diaz Corchero j, M. A., Dietel az, T., Divià ah, R., Di Bari ae, D., Di Liberto dc, S., Di Mauro ah, A., Di Nezza bs, P., Djuvsland q, Ø., Dobrin bd, A., Dobrowolski bx, T., Domenicis Gimenez dm, D., Dönigus ax, B., Dordic u, O., Dorheim di, S., Dubey dx, A. K., Dubla bd, A., Ducroux dv, L., Dupieux bq, P., Dutta Majumdar cu, A. K., Elia cx, D., Engel aw, H., Erazmus ah, B., Erdal aj, H. A., Eschweiler an, D., Espagnon av, B., Estienne df, M., Esumi dt, S., Evans cv, D., Evdokimov bb, S., Eyyubova u, G., Fabris db, D., Faivre br, J., Falchieri z, D., Fantoni bs, A., Fasel cm, M., Fehlker q, D., Feldkamp az, L., Felea bi, D., Feliciello de, A., Feofilov dw, G., Ferencei cd, J., Fernández Téllez b, A., Ferreiro p, E. G., Ferretti y, A., Festanti ab, A., Figiel dj, J., Figueredo dm, M. A. S., Filchagin cs, S., Finogeev bc, D., Fionda ae, F. M., Fiore ae, E. M., Floratos ci, E., Floris ah, M., Foertsch bl, S., Foka cq, P., Fokin ct, S., Francescon ab, A., Frankenfeld cq, U., Fuchs ah, U., Furget br, C., Fusco Girard ac, M., Gaardhøje ca, J. J., Gagliardi y, M., Gallio y, M., Gangadharan s, D. R., Ganoti ce, P., Garabatos cq, C., Garcia Solis m, E., Gargiulo ah, C., Garishvili bv, I., Gerhard an, J., Germain df, M., Gheata ah, A., Gheata ah, M., Ghidini ae, B., Ghosh dx, P., Ghosh d, S. K., Gianotti bs, P., Giubellino ah, P., Gladysz Dziadus dj, E., Glässel cm, P., Gomez k, R., González Zamora j, P., Gorbunov an, S., Görlich dj, L., Gotovac dh, S., Graczykowski dz, L. K., Grajcarek cm, R., Grelli bd, A., Grigoras ah, A., Grigoras ah, C., Grigoriev bw, V., Grigoryan a, A., Grigoryan bm, S., Grinyov c, B., Grion dd, N., Grosse Oetringhaus ah, J. F., Grossiord dv, J. Y., Grosso ah, R., Guber bc, F., Guernane br, R., Guerzoni z, B., Guilbaud dv, M., Gulbrandsen ca, K., Gulkanyan a, H., Gunji ds, T., Gupta ck, A., Gupta ck, R., Khan o, K. H., Haake az, R., Haaland q, Ø., Hadjidakis av, C., Haiduc bi, M., Hamagaki ds, H., Hamar eb, G., Hanratty cv, L. D., Hansen ca, A., Harris ec, J. W., Hartmann an, H., Harton m, A., Hatzifotiadou cy, D., Hayashi ds, S., Hayrapetyan ah, A., A, Heckel ax, S. T., Heide az, M., Helstrup aj, H., Herghelegiu by, A., Herrera Corral k, G., Hess ag, B. A., Hetland aj, K. F., Hicks ec, B., Hippolyte ba, B., Hladky bg, J., Hristov ah, P., Huang q, M., Humanic s, T. J., Hutter an, D., Hwang t, D. S., Ianigro dv, J. C., Ilkaev cs, R., Ilkiv bx, I., Inaba dt, M., Incani w, E., Innocenti y, G. M., Ionita ah, C., Ippolitov ct, M., Irfan r, M., Ivanov cq, M., Ivanov cf, V., Ivanytskyi c, O., Jachołkowski aa, A., Jahnke dm, C., Jang bo, H. J., Janik dz, M. A., Jayarathna do, P. H. S. Y., Jena as, S., Jimenez Bustamante bj, R. T., Jones cv, P. G., Jung ao, H., Jusko cv, A., Kalcher an, S., Kalinak bf, P., Kalweit ah, A., Kamin ax, J., Kang ed, J. H., Kaplin bw, V., Kar dx, S., Karasu Uysal bp, A., Karavichev bc, O., Karavicheva bc, T., Karpechev bc, E., Kebschull aw, U., Keidel ee, R., Ketzer ai, B., Khan r, M. M., 3, Khan cu, P., Khan dx, S. A., Khanzadeev cf, A., Kharlov bb, Y., Kileng aj, B., Kim ed, B., Kim bo, D. W., Kim dp, D. J., Kim ao, J. S., Kim ao, M., Kim ed, M., Kim t, S., Kim ed, T., Kirsch an, S., Kisel an, I., Kiselev be, S., Kisiel dz, A., Kiss eb, G., Klay f, J. L., Klein cm, J., Klein Bösing az, C., Kluge ah, A., Knichel cq, M. L., Knospe dk, A. G., Kobdaj dg, C., Köhler cq, M. K., Kollegger an, T., Kolojvari dw, A., Kondratiev dw, V., Kondratyeva bw, N., Konevskikh bc, A., Kovalenko dw, V., Kowalski dj, M., Kox br, S., Koyithatta Meethaleveedu as, G., Kral dp, J., Králik bf, I., Kramer ax, F., Kravcˇáková am, A., Krelina al, M., Kretz an, M., Krivda cv, M., Krizek cd, F., Krus al, M., Kryshen cf, E., Krzewicki cq, M., Kucˇera cd, V., Kucheriaev ct, Y., Kugathasan ah, T., Kuhn ba, C., Kuijer cb, P. G., Kulakov ax, I., Kumar as, J., Kurashvili bx, P., Kurepin bc, A., Kurepin bc, A. B., Kuryakin cs, A., Kushpil cd, S., Kushpil cd, V., Kweon cm, M. J., Kwon ed, Y., Ladron de Guevara bj, P., Lagana Fernandes dm, C., Lakomov av, I., Langoy dy, R., Lara aw, C., Lardeux df, A., Lattuca y, A., La Pointe bd, S. L., La Rocca aa, P., Lee cv, G. R., Legrand ah, I., Lehnert ax, J., Lemmon cc, R. C., Lenhardt cq, M., Lenti cx, V., Leogrande bd, E., Leoncino y, M., León Monzón dl, I., Lévai eb, P., Li bq, S., G, Lien dy, J., Q, Lietava cv, R., Lindal u, S., Lindenstruth an, V., Lippmann cq, C., Lisa s, M. A., Ljunggren af, H. M., Lodato bd, D. F., Loenne q, P. I., Loggins ea, V. R., Loginov bw, V., Lohner cm, D., Loizides bu, C., Lopez bq, X., López Torres i, E., Lu cm, X. G., Luettig ax, P., Lunardon ab, M., Luo g, J., Luzzi ah, C., Gago cw, A. M., Jacobs bu, P. M., Ma ec, R., Maevskaya bc, A., Mager ah, M., Mahapatra bh, D. P., Maire cm, A., Malaev cf, M., Maldonado Cervantes bj, I., Malinina bm, L., 4, Mal’Kevich be, D., Malzacher cq, P., Mamonov cs, A., Manceau de, L., Manko ct, V., Manso bq, F., Manzari cx, V., Marchisone bq, M., Y, Mareš bg, J., Margotti cy, A., Marín cq, A., Markert ah, C., Marquard ax, M., Martashvili dr, I., Martin cq, N. A., Martinengo ah, P., Martínez b, M. I., Martínez García df, G., Martin Blanco df, J., Martynov c, Y., Mas df, A., Masciocchi cq, S., Masera y, M., Masoni cz, A., Massacrier df, L., Mastroserio ae, A., Matyja dj, A., Mayer dj, C., Mazer dr, J., Mazumder at, R., Mazzoni dc, M. A., Meddi v, F., Menchaca Rocha bk, A., Mercado Pérez cm, J., Meres ak, M., Miake dt, Y., Mikhaylov be, K., Milano ah, L., Milosevic u, J., 5, Mischke bd, A., Mishra at, A. N., Mis ́kowiec cq, D., Mitu bi, C. M., Mlynarz ea, J., Mohanty dx, B., Molnar ba, L., Montaño Zetina k, L., Montes j, E., Morando ab, M., Moreira De Godoy dm, D. A., Moretto ab, S., Morreale dp, A., Morsch ah, A., Muccifora bs, V., Mudnic dh, E., Muhuri dx, S., Mukherjee dx, M., Müller ah, H., Munhoz dm, M. G., Murray cj, S., Musa ah, L., Musinsky bf, J., Nandi as, B. K., Nania cy, R., Nappi cx, E., Nattrass dr, C., Nayak dx, T. K., Nazarenko cs, S., Nedosekin be, A., Nicassio cq, M., Niculescu ah, M., Nielsen ca, B. S., Nikolaev ct, S., Nikulin ct, S., Nikulin cf, V., Nilsen cg, B. S., Noferini l, F., Nomokonov bm, P., Nooren bd, G., Nyanin ct, A., Nyatha as, A., Nystrand q, J., Oeschler cm, H., Oh ec, S., Oh bn, S. K., Ao, 6, Okatan bp, A., Olah eb, L., Oleniacz dz, J., Oliveira Da Silva dm, A. C., Onderwaater cq, J., Oppedisano de, C., Ortiz Velasquez af, A., Oskarsson af, A., Otwinowski cq, J., Oyama cm, K., Pachmayer cm, Y., Pachr al, M., Pagano ac, P., Paic ́ bj, G., Painke an, F., Pajares p, C., Pal dx, S. K., Palmeri da, A., Pant as, D., Papikyan a, V., Pappalardo da, G. S., Park cq, W. J., Passfeld az, A., Patalakha bb, D. I., Paticchio cx, V., Paul cu, B., Pawlak dz, T., Peitzmann bd, T., Pereira Da Costa n, H., Pereira De Oliveira Filho dm, E., Peresunko ct, D., Pérez Lara cb, C. E., Peryt dz, W., Pesci cy, A., Pestov e, Y., Petrácˇek al, V., Petran al, M., Petris by, M., Petrovici by, M., Petta aa, C., Pikna ak, M., Pillot df, P., Pinazza ah, O., Pinsky do, L., Piyarathna do, D. B., Planinic cr, M., Płoskon ́ bu, M., Pluta dz, J., Pochybova eb, S., Podesta Lerma dl, P. L. M., Poghosyan ah, M. G., Pohjoisaho aq, E. H. O., Polichtchouk bb, B., Poljak cr, N., Pop by, A., Porteboeuf Houssais bq, S., Porter bu, J., Pospisil al, V., Potukuchi ck, B., Prasad ea, S. K., D, Preghenella cy, R., Prino de, F., Pruneau ea, C. A., Pshenichnov bc, I., Puddu w, G., Pujahari ea, P., Punin cs, V., Putschke ea, J., Qvigstad u, H., Rachevski dd, A., Raha d, S., Rak dp, J., Rakotozafindrabe n, A., Ramello ad, L., Raniwala cl, R., Raniwala cl, S., Räsänen aq, S. S., Rascanu ax, B. T., Rathee ch, D., Rauf o, A. W., Razazi w, V., Read dr, K. F., Real br, J. S., Redlich bx, K., 7, Reed ec, R. J., Rehman q, A., Reichelt ax, P., Reicher bd, M., Reidt ah, F., Renfordt ax, R., Reolon bs, A. R., Reshetin bc, A., Rettig an, F., Revol ah, J. P., Reygers cm, K., Riabov cf, V., Ricci bt, R. A., Richert af, T., Richter u, M., Riedler ah, P., Riegler ah, W., Riggi aa, F., Rivetti de, A., Rocco bd, E., Rodríguez Cahuantzi b, M., Rodriguez Manso cb, A., Røed u, K., Rogochaya bm, E., Rohni ck, S., Rohr an, D., Röhrich q, D., Romita dq, R., Ronchetti bs, F., Ronflette df, L., Rosnet bq, P., Rossegger ah, S., Rossi ah, A., Roy at, A., Roy ba, C., Roy cu, P., Rubio Montero j, A. J., Russo y, R., Ryabinkin ct, E., Ryabov cf, Y., Rybicki dj, A., Sadovsky bb, S., Šafarˇík ah, K., Sahlmuller ax, B., Sahoo at, R., Sahu bh, P. K., Saini dx, J., Salgado p, C. A., Salzwedel s, J., Sambyal ck, S., Samsonov cf, V., Sanchez Castro ba, X., Sánchez Rodríguez dl, F. J., Šándor bf, L., Sandoval bk, A., Sano dt, M., Santagati aa, G., Sarkar dx, D., Scapparone cy, E., Scarlassara ab, F., Scharenberg co, R. P., Schiaua by, C., Schicker cm, R., Schmidt cq, C., Schmidt ag, H. R., Schuchmann ax, S., Schukraft ah, J., Schulc al, M., Schuster ec, T., Schutz ah, Y., Schwarz cq, K., Schweda cq, K., Scioli z, G., Scomparin de, E., Scott cv, P. A., Scott dr, R., Segato ab, G., Seger cg, J. E., Selyuzhenkov cq, I., Seo cp, J., Serradilla j, E., Sevcenco bi, A., Shabetai df, A., Shabratova bm, G., Shahoyan ah, R., Shangaraev bb, A., Sharma dr, N., Sharma ck, S., Shigaki ar, K., Shtejer y, K., Sibiriak ct, Y., Siddhanta cz, S., Siemiarczuk bx, T., Silvermyr ce, D., Silvestre br, C., Simatovic du, G., Singaraju dx, R., Singh ck, R., Singha bz, S., Singhal dx, V., Sinha dx, B. C., Sinha cu, T., Sitar ak, B., Sitta ad, M., Skaali u, T. B., Skjerdal q, K., Smakal al, R., Smirnov ec, N., Snellings bd, R. J. M., Søgaard af, C., Soltz bv, R., Song cp, J., Song ed, M., Soramel ab, F., Sorensen dr, S., Spacek al, M., Sputowska dj, I., Spyropoulou Stassinaki ci, M., Srivastava co, B. K., Stachel cm, J., Stan bi, I., Stefanek bx, G., Steinpreis s, M., Stenlund af, E., Steyn bl, G., Stiller cm, J. H., Stocco df, D., Stolpovskiy bb, M., Strmen ak, P., Suaide dm, A. A. P., Subieta Vasquez y, M. A., Sugitate ar, T., Suire av, C., Suleymanov o, M., Sultanov be, R., Šumbera cd, M., Susa cr, T., Symons bu, T. J. M., Szanto de Toledo dm, A., Szarka ak, I., Szczepankiewicz ah, A., Szymanski dz, M., Takahashi dn, J., Tangaro ae, M. A., Tapia Takaki av, J. D., 8, Tarantola Peloni ax, A., Tarazona Martinez ah, A., Tauro ah, A., Tejeda Muñoz b, G., Telesca ah, A., Terrevoli ae, C., Ter Minasyan ct, A., Thäder cq, J., Thomas bd, D., Tieulent dv, R., Timmins do, A. R., Toia db, A., Torii ds, H., Trubnikov c, V., Trzaska dp, W. H., Tsuji ds, T., Tumkin cs, A., Turrisi db, R., Tveter u, T. S., Ulery ax, J., Ullaland q, K., Ulrich aw, J., Uras dv, A., Usai w, G. L., Vajzer cd, M., Vala bf, M., Valencia Palomo bq, L., Vallero y, S., Vande Vyvre ah, P., Vannucci bt, L., Van Hoorne ah, J. W., van Leeuwen bd, M., Vargas b, A., Varma as, R., Vasileiou ci, M., Vasiliev ct, A., Vechernin dw, V., Veldhoen bd, M., Venaruzzo x, M., Vercellin y, E., Vergara Limón b, S., Vernet h, R., Verweij ea, M., Vickovic dh, L., Viesti ab, G., Viinikainen dp, J., Vilakazi bl, Z., Villalobos Baillie cv, O., Vinogradov ct, A., Vinogradov dw, L., Vinogradov cs, Y., Virgili ac, T., Viyogi dx, Y. P., Vodopyanov bm, A., Völkl cm, M. A., Voloshin be, K., Voloshin ea, S. A., Volpe ah, G., von Haller ah, B., Vorobyev dw, I., Vranic cq, D., Vrláková am, J., Vulpescu bq, B., Vyushin cs, A., Wagner q, B., Wagner cq, J., Wagner al, V., Wang g, M., Wang cm, Y., Watanabe dt, D., Weber do, M., Wessels az, J. P., Westerhoff az, U., Wiechula ag, J., Wikne u, J., Wilde az, M., Wilk bx, G., Wilkinson cm, J., Williams cy, M. C. S., Windelband cm, B., Winn cm, M., Xiang g, C., Yaldo ea, C. G., Yamaguchi ds, Y., Yang n, H., Yang g, P., Yang q, S., Yano ar, S., Yasnopolskiy ct, S., Yi cp, J., Yin g, Z., Yoo cp, I. K., Yushmanov ct, I., Zaccolo ca, V., Zach al, C., Zaman o, A., Zampolli cy, C., Zaporozhets bm, S., Zarochentsev dw, A., Závada bg, P., Zaviyalov cs, N., Zbroszczyk dz, H., Zgura bi, I. S., Zhalov cf, M., Zhang g, F., Zhang g, H., Zhang bq, X., Bu, G, Zhang g, Y., Zhao u, C., Zhou g, D., Zhou g, F., Zhou bd, Y., Zhu g, H., Zhu g, J., Zhu g, X., Zichichi l, A., Zimmermann cm, A., Zimmermann ah, M. B., Zinovjev c, G., Zoccarato dv, Y., Zynovyev c, M., Zyzak, M., Contin, Giacomo, Piano, Stefano, Lea, Ramona, Camerini, Paolo, Luparello, Grazia, Fragiacomo, Enrico, Margagliotti, Giacomo, Rui, Rinaldo, B., Abelev bv, J., Adam al, D., Adamová cd, M. M., Aggarwal ch, G., Aglieri Rinella ah, M., Agnello cn, De, A. G., Agocs eb, A., Agostinelli z, N., Agrawal a, Z., Ahammed dx, N., Ahmad r, A., Ahmad Masoodi r, I., Ahmed o, S. U., Ahn bo, S. A., Ahn bo, I., Aimo de, Cn, S., Aiola ec, M., Ajaz o, A., Akindinov be, D., Aleksandrov ct, B., Alessandro de, D., Alexandre cv, A., Alici l, Cy, A., Alkin c, J., Alme aj, T., Alt an, V., Altini ae, S., Altinpinar q, I., Altsybeev dw, C., Alves Garcia Prado dm, C., Andrei by, A., Andronic cq, V., Anguelov cm, J., Anielski az, T., Anticˇic ́ cr, F., Antinori db, P., Antonioli cy, L., Aphecetche df, H., Appelshäuser ax, N., Arbor br, S., Arcelli z, N., Armesto p, R., Arnaldi de, T., Aronsson ec, I. C., Arsene u, Cq, M., Arslandok ax, A., Augustinus ah, R., Averbeck cq, T. C., Awes ce, M. D., Azmi r, Cj, M., Bach an, A., Badalà da, Y. W., Baek ao, Bq, S., Bagnasco de, R., Bailhache ax, V., Bairathi cl, R., Bala ck, A., Baldisseri n, F., Baltasar Dos Santos Pedrosa ah, J., Bán bf, R. C., Baral bh, R., Barbera aa, F., Barile ae, G. G., Barnaföldi eb, L. S., Barnby cv, V., Barret bq, J., Bartke dj, M., Basile z, N., Bastid bq, S., Basu dx, B., Bathen az, G., Batigne df, B., Batyunya bm, P. C., Batzing u, C., Baumann ax, I. G., Bearden ca, H., Beck ax, C., Bedda cn, N. K., Behera a, I., Belikov ba, F., Bellini z, R., Bellwied do, E., Belmont Moreno bk, G., Bencedi eb, S., Beole y, I., Berceanu by, A., Bercuci by, Y., Berdnikov cf, D., Berenyi eb, M. E., Berger di, A. A. E., Bergognon df, R. A., Bertens bd, D., Berzano y, L., Betev ah, A., Bhasin ck, A. K., Bhati ch, B., Bhattacharjee ap, J., Bhom dt, L., Bianchi y, N., Bianchi b, C., Bianchin bd, J., Bielcˇík al, J., Bielcˇíková cd, A., Bilandzic ca, S., Bjelogrlic bd, F., Blanco j, D., Blau ct, C., Blume ax, F., Bock bu, Cm, F. V., Boehmer di, A., Bogdanov bw, H., Bøggild ca, M., Bogolyubsky bb, L., Boldizsár eb, M., Bombara am, J., Book ax, H., Borel n, A., Borissov cp, Ea, J., Bornschein an, F., Bossú bl, M., Botje cb, E., Botta y, S., Böttger aw, P., Braun Munzinger cq, M., Bregant dm, Df, T., Breitner aw, T. A., Broker ax, T. A., Browning co, M., Broz ak, E., Bruna de, G. E., Bruno ae, D., Budnikov c, H., Buesching ax, S., Bufalino de, P., Buncic ah, O., Busch cm, Z., Buthelezi bl, D., Caffarri ab, X., Cai g, H., Caines ec, A., Caliva bd, E., Calvo Villar cw, V., Canoa Roman ah, F., Carena ah, W., Carena ah, F., Carminati ah, A., Casanova Díaz b, J., Castillo Castellanos n, E. A. R., Casula w, V., Catanescu by, C., Cavicchioli ah, C., Ceballos Sanchez i, J., Cepila al, P., Cerello de, B., Chang dp, S., Chapeland ah, J. L., Charvet n, S., Chattopadhyay dx, S., Chattopadhyay cu, M., Cherney cg, C., Cheshkov dv, B., Cheynis dv, V., Chibante Barroso ah, D. D., Chinellato do, Dn, P., Chochula ah, M., Chojnacki ca, S., Choudhury dx, P., Christakoglou cb, C. H., Christensen ca, P., Christiansen af, T., Chujo dt, S. U., Chung cp, C., Cicalo cz, L., Cifarelli l, Z, F., Cindolo cy, J., Cleymans cj, F., Colamaria ae, D., Colella ae, A., Collu w, M., Colocci z, G., Conesa Balbastre br, Z., Conesa del Valle av, Ah, M. E., Connors ec, G., Contin x, J. G., Contreras k, T. M., Cormier ce, Y., Corrales Morales y, P., Cortese ad, I., Cortés Maldonado b, M. R., Cosentino bu, Dm, F., Costa ah, P., Crochet bq, R., Cruz Albino k, E., Cuautle bj, L., Cunqueiro b, A., Dainese db, R., Dang g, A., Danu bi, D., Das cu, I., Das av, K., Das cu, S., Das d, A., Dash dn, S., Dash a, S., De dx, H., Delagrange df, A., Deloff bx, E., Dénes eb, G., D’Erasmo ae, G. O. V., de Barros dm, A., De Caro l, Ac, G., de Cataldo cx, J., de Cuveland an, A., De Falco w, D., De Gruttola ac, L, N., De Marco de, S., De Pasquale ac, R., de Rooij bd, M. A., Diaz Corchero j, T., Dietel az, R., Divià ah, D., Di Bari ae, S., Di Liberto dc, A., Di Mauro ah, P., Di Nezza b, Ø., Djuvsland q, A., Dobrin bd, T., Dobrowolski bx, D., Domenicis Gimenez dm, B., Dönigus ax, O., Dordic u, S., Dorheim di, A. K., Dubey dx, A., Dubla bd, L., Ducroux dv, P., Dupieux bq, A. K., Dutta Majumdar cu, D., Elia cx, H., Engel aw, B., Erazmus ah, H. A., Erdal aj, D., Eschweiler an, B., Espagnon av, M., Estienne df, S., Esumi dt, D., Evans cv, S., Evdokimov bb, G., Eyyubova u, D., Fabris db, J., Faivre br, D., Falchieri z, A., Fantoni b, M., Fasel cm, D., Fehlker q, L., Feldkamp az, D., Felea bi, A., Feliciello de, G., Feofilov dw, J., Ferencei cd, A., Fernández Téllez b, E. G., Ferreiro p, A., Ferretti y, A., Festanti ab, J., Figiel dj, M. A. S., Figueredo dm, Dq, S., Filchagin c, D., Finogeev bc, F. M., Fionda ae, E. M., Fiore ae, E., Floratos ci, M., Floris ah, S., Foertsch bl, P., Foka cq, S., Fokin ct, A., Francescon ab, U., Frankenfeld cq, U., Fuchs ah, C., Furget br, M., Fusco Girard ac, J. J., Gaardhøje ca, M., Gagliardi y, M., Gallio y, D. R., Gangadharan, Bu, P., Ganoti ce, Ci, C., Garabatos cq, E., Garcia Solis m, C., Gargiulo ah, I., Garishvili bv, J., Gerhard an, M., Germain df, A., Gheata ah, M., Gheata ah, Bi, B., Ghidini ae, P., Ghosh dx, S. K., Ghosh d, P., Gianotti b, P., Giubellino ah, E., Gladysz Dziadus dj, P., Glässel cm, R., Gomez k, P., González Zamora j, S., Gorbunov an, L., Görlich dj, S., Gotovac dh, L. K., Graczykowski dz, R., Grajcarek cm, A., Grelli bd, A., Grigoras ah, C., Grigoras ah, V., Grigoriev bw, A., Grigoryan a, S., Grigoryan bm, B., Grinyov c, N., Grion dd, J. F., Grosse Oetringhaus ah, J. Y., Grossiord dv, R., Grosso ah, F., Guber bc, R., Guernane br, B., Guerzoni z, M., Guilbaud dv, K., Gulbrandsen ca, H., Gulkanyan a, T., Gunji d, A., Gupta ck, R., Gupta ck, K. H., Khan o, R., Haake az, Ø., Haaland q, C., Hadjidakis av, M., Haiduc bi, H., Hamagaki d, G., Hamar eb, L. D., Hanratty cv, A., Hansen ca, J. W., Harris ec, H., Hartmann an, A., Harton m, D., Hatzifotiadou cy, S., Hayashi d, A., Hayrapetyan ah, A, S. T., Heckel ax, M., Heide az, H., Helstrup aj, A., Herghelegiu by, G., Herrera Corral k, B. A., Hess ag, K. F., Hetland aj, B., Hicks ec, B., Hippolyte ba, J., Hladky bg, P., Hristov ah, M., Huang q, T. J., Humanic, D., Hutter an, D. S., Hwang t, J. C., Ianigro dv, R., Ilkaev c, I., Ilkiv bx, M., Inaba dt, E., Incani w, G. M., Innocenti y, C., Ionita ah, M., Ippolitov ct, M., Irfan r, M., Ivanov cq, V., Ivanov cf, O., Ivanytskyi c, A., Jachołkowski aa, C., Jahnke dm, H. J., Jang bo, M. A., Janik dz, P. H. S. Y., Jayarathna do, S., Jena a, Do, R. T., Jimenez Bustamante bj, P. G., Jones cv, H., Jung ao, A., Jusko cv, S., Kalcher an, P., Kalinak bf, A., Kalweit ah, J., Kamin ax, J. H., Kang ed, V., Kaplin bw, S., Kar dx, A., Karasu Uysal bp, O., Karavichev bc, T., Karavicheva bc, E., Karpechev bc, U., Kebschull aw, R., Keidel ee, B., Ketzer ai, Di, M. M., Khan r, P., Khan cu, S. A., Khan dx, A., Khanzadeev cf, Y., Kharlov bb, B., Kileng aj, B., Kim ed, D. W., Kim bo, Ao, D. J., Kim dp, J. S., Kim ao, M., Kim ao, M., Kim ed, S., Kim t, T., Kim ed, S., Kirsch an, I., Kisel an, S., Kiselev be, A., Kisiel dz, G., Kiss eb, J. L., Klay f, J., Klein cm, C., Klein Bösing az, A., Kluge ah, M. L., Knichel cq, A. G., Knospe dk, C., Kobdaj dg, M. K., Köhler cq, T., Kollegger an, A., Kolojvari dw, V., Kondratiev dw, N., Kondratyeva bw, A., Konevskikh bc, V., Kovalenko dw, M., Kowalski dj, S., Kox br, G., Koyithatta Meethaleveedu a, J., Kral dp, I., Králik bf, F., Kramer ax, A., Kravcˇáková am, M., Krelina al, M., Kretz an, M., Krivda cv, Bf, F., Krizek cd, Aq, M., Krus al, E., Kryshen cf, M., Krzewicki cq, V., Kucˇera cd, Y., Kucheriaev ct, T., Kugathasan ah, C., Kuhn ba, P. G., Kuijer cb, I., Kulakov ax, J., Kumar a, P., Kurashvili bx, A., Kurepin bc, A. B., Kurepin bc, A., Kuryakin c, S., Kushpil cd, V., Kushpil cd, M. J., Kweon cm, Au, Y., Kwon ed, P., Ladron de Guevara bj, C., Lagana Fernandes dm, I., Lakomov av, R., Langoy dy, C., Lara aw, A., Lardeux df, A., Lattuca y, S. L., La Pointe bd, P., La Rocca aa, G. R., Lee cv, I., Legrand ah, J., Lehnert ax, R. C., Lemmon cc, M., Lenhardt cq, V., Lenti cx, E., Leogrande bd, M., Leoncino y, I., León Monzón dl, P., Lévai eb, S., Li bq, G, J., Lien dy, Q, R., Lietava cv, S., Lindal u, V., Lindenstruth an, C., Lippmann cq, M. A., Lisa, H. M., Ljunggren af, D. F., Lodato bd, P. I., Loenne q, V. R., Loggins ea, V., Loginov bw, D., Lohner cm, C., Loizides bu, X., Lopez bq, E., López Torres i, X. G., Lu cm, P., Luettig ax, M., Lunardon ab, J., Luo g, C., Luzzi ah, A. M., Gago cw, P. M., Jacobs bu, R., Ma ec, A., Maevskaya bc, M., Mager ah, D. P., Mahapatra bh, A., Maire cm, Ba, M., Malaev cf, I., Maldonado Cervantes bj, L., Malinina bm, D., Mal’Kevich be, P., Malzacher cq, A., Mamonov c, L., Manceau de, V., Manko ct, F., Manso bq, V., Manzari cx, M., Marchisone bq, Y, J., Mareš bg, A., Margotti cy, A., Marín cq, C., Markert ah, Dk, M., Marquard ax, I., Martashvili dr, N. A., Martin cq, P., Martinengo ah, M. I., Martínez b, G., Martínez García df, J., Martin Blanco df, Y., Martynov c, A., Mas df, S., Masciocchi cq, M., Masera y, A., Masoni cz, L., Massacrier df, A., Mastroserio ae, A., Matyja dj, C., Mayer dj, J., Mazer dr, R., Mazumder at, M. A., Mazzoni dc, F., Meddi v, A., Menchaca Rocha bk, J., Mercado Pérez cm, M., Meres ak, Y., Miake dt, K., Mikhaylov be, Bm, L., Milano ah, J., Milosevic u, A., Mischke bd, A. N., Mishra at, D., Mis ́kowiec cq, C. M., Mitu bi, J., Mlynarz ea, B., Mohanty dx, Bz, L., Molnar ba, L., Montaño Zetina k, E., Montes j, M., Morando ab, D. A., Moreira De Godoy dm, S., Moretto ab, A., Morreale dp, A., Morsch ah, V., Muccifora b, E., Mudnic dh, S., Muhuri dx, M., Mukherjee dx, H., Müller ah, M. G., Munhoz dm, S., Murray cj, Bl, L., Musa ah, J., Musinsky bf, B. K., Nandi a, R., Nania cy, E., Nappi cx, C., Nattrass dr, T. K., Nayak dx, S., Nazarenko c, A., Nedosekin be, M., Nicassio cq, M., Niculescu ah, B. S., Nielsen ca, S., Nikolaev ct, S., Nikulin ct, V., Nikulin cf, B. S., Nilsen cg, F., Noferini l, P., Nomokonov bm, G., Nooren bd, A., Nyanin ct, A., Nyatha a, J., Nystrand q, H., Oeschler cm, Ay, S., Oh ec, S. K., Oh bn, Ao, 6, A., Okatan bp, L., Olah eb, J., Oleniacz dz, A. C., Oliveira Da Silva dm, J., Onderwaater cq, C., Oppedisano de, A., Ortiz Velasquez af, A., Oskarsson af, J., Otwinowski cq, K., Oyama cm, Y., Pachmayer cm, M., Pachr al, P., Pagano ac, G., Paic ́ bj, F., Painke an, C., Pajares p, S. K., Pal dx, A., Palmeri da, D., Pant a, V., Papikyan a, G. S., Pappalardo da, W. J., Park cq, A., Passfeld az, D. I., Patalakha bb, V., Paticchio cx, B., Paul cu, T., Pawlak dz, T., Peitzmann bd, H., Pereira Da Costa n, E., Pereira De Oliveira Filho dm, D., Peresunko ct, C. E., Pérez Lara cb, W., Peryt dz, A., Pesci cy, Y., Pestov e, V., Petrácˇek al, M., Petran al, M., Petris by, M., Petrovici by, C., Petta aa, M., Pikna ak, P., Pillot df, O., Pinazza ah, L., Pinsky do, D. B., Piyarathna do, M., Planinic cr, Du, M., Płoskon ́ bu, J., Pluta dz, S., Pochybova eb, P. L. M., Podesta Lerma dl, M. G., Poghosyan ah, Cg, E. H. O., Pohjoisaho aq, B., Polichtchouk bb, N., Poljak cr, A., Pop by, S., Porteboeuf Houssais bq, J., Porter bu, V., Pospisil al, B., Potukuchi ck, S. K., Prasad ea, D, R., Preghenella cy, F., Prino de, C. A., Pruneau ea, I., Pshenichnov bc, G., Puddu w, P., Pujahari ea, As, V., Punin c, J., Putschke ea, H., Qvigstad u, A., Rachevski dd, S., Raha d, J., Rak dp, A., Rakotozafindrabe n, L., Ramello ad, R., Raniwala cl, S., Raniwala cl, S. S., Räsänen aq, B. T., Rascanu ax, D., Rathee ch, A. W., Rauf o, V., Razazi w, K. F., Read dr, J. S., Real br, K., Redlich bx, R. J., Reed ec, A., Rehman q, P., Reichelt ax, M., Reicher bd, F., Reidt ah, R., Renfordt ax, A. R., Reolon b, A., Reshetin bc, F., Rettig an, J. P., Revol ah, K., Reygers cm, V., Riabov cf, R. A., Ricci bt, T., Richert af, M., Richter u, P., Riedler ah, W., Riegler ah, F., Riggi aa, A., Rivetti de, E., Rocco bd, M., Rodríguez Cahuantzi b, A., Rodriguez Manso cb, K., Røed u, E., Rogochaya bm, S., Rohni ck, D., Rohr an, D., Röhrich q, R., Romita dq, Cc, F., Ronchetti b, L., Ronflette df, P., Rosnet bq, S., Rossegger ah, A., Rossi ah, A., Roy at, C., Roy ba, P., Roy cu, A. J., Rubio Montero j, R., Russo y, E., Ryabinkin ct, Y., Ryabov cf, A., Rybicki dj, S., Sadovsky bb, K., Šafarˇík ah, B., Sahlmuller ax, R., Sahoo at, P. K., Sahu bh, J., Saini dx, C. A., Salgado p, J., Salzwedel, S., Sambyal ck, V., Samsonov cf, X., Sanchez Castro ba, Bj, F. J., Sánchez Rodríguez dl, L., Šándor bf, A., Sandoval bk, M., Sano dt, G., Santagati aa, D., Sarkar dx, E., Scapparone cy, F., Scarlassara ab, R. P., Scharenberg co, C., Schiaua by, R., Schicker cm, C., Schmidt cq, H. R., Schmidt ag, S., Schuchmann ax, J., Schukraft ah, M., Schulc al, T., Schuster ec, Y., Schutz ah, K., Schwarz cq, K., Schweda cq, G., Scioli z, E., Scomparin de, P. A., Scott cv, R., Scott dr, G., Segato ab, J. E., Seger cg, I., Selyuzhenkov cq, J., Seo cp, E., Serradilla j, Bk, A., Sevcenco bi, A., Shabetai df, G., Shabratova bm, R., Shahoyan ah, A., Shangaraev bb, N., Sharma dr, Bh, S., Sharma ck, K., Shigaki ar, K., Shtejer y, Y., Sibiriak ct, S., Siddhanta cz, T., Siemiarczuk bx, D., Silvermyr ce, C., Silvestre br, G., Simatovic du, R., Singaraju dx, R., Singh ck, S., Singha bz, Dx, V., Singhal dx, B. C., Sinha dx, T., Sinha cu, B., Sitar ak, M., Sitta ad, T. B., Skaali u, K., Skjerdal q, R., Smakal al, N., Smirnov ec, R. J. M., Snellings bd, C., Søgaard af, R., Soltz bv, J., Song cp, M., Song ed, F., Soramel ab, S., Sorensen dr, M., Spacek al, I., Sputowska dj, M., Spyropoulou Stassinaki ci, B. K., Srivastava co, J., Stachel cm, I., Stan bi, G., Stefanek bx, M., Steinpreis, E., Stenlund af, G., Steyn bl, J. H., Stiller cm, D., Stocco df, M., Stolpovskiy bb, P., Strmen ak, A. A. P., Suaide dm, M. A., Subieta Vasquez y, T., Sugitate ar, C., Suire av, M., Suleymanov o, R., Sultanov be, M., Šumbera cd, T., Susa cr, T. J. M., Symons bu, A., Szanto de Toledo dm, I., Szarka ak, A., Szczepankiewicz ah, M., Szymanski dz, J., Takahashi dn, M. A., Tangaro ae, J. D., Tapia Takaki av, A., Tarantola Peloni ax, A., Tarazona Martinez ah, A., Tauro ah, G., Tejeda Muñoz b, A., Telesca ah, C., Terrevoli ae, A., Ter Minasyan ct, Bw, J., Thäder cq, D., Thomas bd, R., Tieulent dv, A. R., Timmins do, A., Toia db, Ax, H., Torii d, V., Trubnikov c, W. H., Trzaska dp, T., Tsuji d, A., Tumkin c, R., Turrisi db, T. S., Tveter u, J., Ulery ax, K., Ullaland q, J., Ulrich aw, A., Uras dv, G. L., Usai w, M., Vajzer cd, M., Vala bf, L., Valencia Palomo bq, Av, S., Vallero y, P., Vande Vyvre ah, L., Vannucci bt, J. W., Van Hoorne ah, M., van Leeuwen bd, A., Vargas b, R., Varma a, M., Vasileiou ci, A., Vasiliev ct, V., Vechernin dw, M., Veldhoen bd, M., Venaruzzo x, E., Vercellin y, S., Vergara Limón b, R., Vernet h, M., Verweij ea, L., Vickovic dh, G., Viesti ab, J., Viinikainen dp, Z., Vilakazi bl, O., Villalobos Baillie cv, A., Vinogradov ct, L., Vinogradov dw, Y., Vinogradov c, T., Virgili ac, Y. P., Viyogi dx, A., Vodopyanov bm, M. A., Völkl cm, K., Voloshin be, S. A., Voloshin ea, G., Volpe ah, B., von Haller ah, I., Vorobyev dw, D., Vranic cq, J., Vrláková am, B., Vulpescu bq, A., Vyushin c, B., Wagner q, J., Wagner cq, V., Wagner al, M., Wang g, Y., Wang cm, D., Watanabe dt, M., Weber do, J. P., Wessels az, U., Westerhoff az, J., Wiechula ag, J., Wikne u, M., Wilde az, G., Wilk bx, J., Wilkinson cm, M. C. S., Williams cy, B., Windelband cm, M., Winn cm, C., Xiang g, C. G., Yaldo ea, Y., Yamaguchi d, H., Yang n, Bd, P., Yang g, S., Yang q, S., Yano ar, S., Yasnopolskiy ct, J., Yi cp, Z., Yin g, I. K., Yoo cp, I., Yushmanov ct, Zaccolo ca, V., C., Zach al, A., Zaman o, C., Zampolli cy, S., Zaporozhets bm, A., Zarochentsev dw, P., Závada bg, N., Zaviyalov c, H., Zbroszczyk dz, I. S., Zgura bi, M., Zhalov cf, F., Zhang g, H., Zhang g, X., Zhang bq, G, Bu, Y., Zhang g, C., Zhao u, D., Zhou g, F., Zhou g, Y., Zhou bd, H., Zhu g, J., Zhu g, X., Zhu g, A., Zichichi l, A., Zimmermann cm, M. B., Zimmermann ah, Az, G., Zinovjev c, Y., Zoccarato dv, M., Zynovyev c, M., Zyzak, and Contin, Giacomo
- Subjects
Relativistic heavy ion collisions ,Quarkonium ,J/ψ suppression ,Quark gluon plasma ,Experimental results ,Relativistic heavy ion collision - Abstract
The inclusive J/ψ nuclear modification factor (RAA) in Pb–Pb collisions at √sNN = 2.76 TeV has been measured by ALICE as a function of centrality in the e+e− decay channel at mid-rapidity (|y| < 0.8) and as a function of centrality, transverse momentum and rapidity in the μ+μ− decay channel at forward-rapidity (2.5 < y < 4). The J/ψ yields measured in Pb–Pb are suppressed compared to those in pp collisions scaled by the number of binary collisions. The RAA integrated over a centrality range corresponding to 90% of the inelastic Pb–Pb cross section is 0.72±0.06(stat.)±0.10(syst.) at mid-rapidity and 0.58 ± 0.01(stat.) ± 0.09(syst.) at forward-rapidity. At low transverse momentum, significantly larger values of RAA are measured at forward-rapidity compared to measurements at lower energy. These features suggest that a contribution to the J/ψ yield originates from charm quark (re)combination in the deconfined partonic medium.
- Published
- 2014
5. Brucellosis in Dogs
- Author
-
Silva Nam, Brasão Sc, Silva Dm, Bisinoto Mb, Vieira Rbk, Eurides D, and Lima Amc
- Subjects
Veterinary medicine ,Canis ,biology ,business.industry ,Ehrlichia sp ,Zoonosis ,Medicine ,Brucellosis ,Brucella ,Erlichiosis ,business ,biology.organism_classification ,medicine.disease - Abstract
The brucellosis is a cronical contagious disease that affects animals and humans, been characterized as a zoonosis. The present study aimed to the detection of brucelosis in 66 dogs examined at the Veterinary Hospital of the Federal University of Uberlândia, naturally infected with Ehrlichia sp. For this study, two species of Brucella were selected, B. abortus and B. canis. For B. abortus the disease was diagnosed with the Rose Bengal Test, confirmed by the ME-RSAT test, and the B. canis was dignosed by a Veterinary Diagnostic comercial kit specifically for it. The prevalence of B. abortus was found in 16 of the 66 dogs evaluated (24.24%), with five confirmed by the ME-RSAT test, and no reagent for B. canis. Positive animals had mainly reproductive problems. With the presented results, it can be concluded that brucellosis is a present disease in dogs and probably have being neglected by the occurrence of erlichiosis at the same time.
- Published
- 2016
- Full Text
- View/download PDF
6. A temática como possibilidade de intersubjetividade: uma opção da revista texto & contexto - enfermagem
- Author
-
da Silva Dm and Maria Itayra Padilha
- Subjects
lcsh:RT1-120 ,lcsh:Nursing ,business.industry ,Exploratory research ,nursing magazines ,Context (language use) ,periódicos de enfermería ,enfermería ,nursing periodics ,nursing ,Nursing ,Health care ,enfermagem ,Sociology ,business ,periódicos de enfermagem ,General Nursing ,Intersubjectivity ,Graduation ,Theme (narrative) - Abstract
Trata-se de uma pesquisa exploratório-descritiva que teve como objetivo realizar uma análise crítica da Revista Texto & Contexto - Enfermagem, enquanto opção temática. Analisamos 18 números da revista publicados entre 19922000, com dois instrumentos para avaliar o inter-relacionamento das temáticas em relação a: aderência às linhas de pesquisa do Programa de Pós-Graduação em Enfermagem da UFSC (PEN/UFSC); ao tipo de artigo publicado; a origem e ao perfil dos autores da Revista. Verificamos que as temáticas são aderentes às Linhas de Pesquisa da PEN/UFSC; a média do número de artigos publicados por revista é 23, 88, o predomínio é de reflexões e de pesquisas; a maioria dos autores são doutores e mestres não docentes da UFSC; o índice de rejeição de artigos foi 11, 86%. A revista atende a maioria dos critérios essenciais e complementares estabelecidos pela CAPES. Destaca-se a aceitação da Revista como temática pela comunidade científica brasileira, pois trouxe uma nova dimensão no cenário das publicações na área da saúde. The present study is a descriptive and exploratory research which has as its objective accomplishing a critical analysis of the magazine "Texto e Contexto - Enfermagem" (Nursing - Text and Context), as a thematic option. Eighteen issues of the magazine, published between 1992 and 2000, were analyzed. Two instruments were used to evaluate the interrelation of the themes with the lines of research of the Post Graduation Program of Nursing in the Federal University of Santa Catarina (PEN/UFSC) in Brazil; the type of articles published; and the origin and profile of the authors of the magazine. It was verified that: the themes in the magazine are linked to the lines of research of PEN/UFSC; the average of articles published per issue is 23, 88%; the majority of the articles are reflections and researches; most of the authors have a masters or doctors degree and do not teach at UFSC; and the rejection rate of the articles was 11, 86%. The magazine bears most of the essential and complementary criteria established by CAPES and has great acceptance of among the Brazilian scientific community, since it brought a new dimension to the health care publications. Se trata de una investigación exploratorio-descriptiva, con el fin de realizar un análisis crítico de la Revista Texto & Contexto- Enfermería, en cuanto opción temática. Analizamos 18 números publicados entre 1992-2000, con dos instrumentos para evaluar la interrelación de las temáticas respecto a: adherencia a las líneas de investigación del Programa de Posgrado en Enfermería de la UFSC ; al tipo de artículo publicado; al origen y perfil de los autores de la Revista. Verificamos que las temáticas son adherentes a las líneas de Investigación de la UFSC; la media del número de artículos publicados por revista es el 23, 88 y predominan las reflexiones e investigaciones; la mayoría de los autores tienen el título de doctor y master no docentes de la UFSC; el índice de rechazo de artículos fue el 11, 86%. La revista atiende a la mayoría de los criterios esenciales y complementares establecidos por la CAPES. Como temática, se destaca la buena recepción de la Revista por la comunidad científica brasileña, ya que ha traído una nueva dimensión al escenario de las publicaciones en el área de la salud.
- Published
- 2002
7. Teamwork in primary health care in Brazil: potentialities and challenges for an integrated care
- Author
-
Pinheiro, GML, primary, Bispo Júnior, JP, additional, Moreira, DC, additional, Chaves, IO, additional, Silva, DM, additional, and Couto, DA, additional
- Published
- 2016
- Full Text
- View/download PDF
8. Professional education in primary health care: experience and challenges in municipalities of Brazil
- Author
-
Pinheiro, GML, primary, Bispo Júnior, JP, additional, Moreira, DC, additional, Chaves, IO, additional, Silva, DM, additional, and Couto, DA, additional
- Published
- 2016
- Full Text
- View/download PDF
9. Visceral Leishmaniasis in Renal Transplant Recipients: Study of 30 Cases
- Author
-
Chave, Barros da Silva Dm, and Alves Da Silva A
- Subjects
Nephrology ,medicine.medical_specialty ,biology ,business.industry ,Disease ,Omics ,medicine.disease ,Leishmania ,biology.organism_classification ,Surgery ,Transplantation ,Visceral leishmaniasis ,Renal transplant ,Internal medicine ,medicine ,Liposomal amphotericin ,business - Abstract
Introduction: Visceral leishmaniasis is a disease caused by the protozoan Leishmania sp. and is transmitted by Lutzomyia longipalpis (sand fly). In renal transplant recipients, Visceral Leishmaniasis causes severe damage to the liver, spleen, and hematopoietic system as well as poor outcomes for patients and transplanted kidneys. This study describes the largest series of cases of this disease in renal transplant recipients, providing important information about the diagnostic routines and therapeutic strategies in this patient population. Methods: A retrospective, descriptive study was performed to analyze the distribution and evaluate the extent of the epidemiologic, clinical, diagnostic, and therapeutic aspects of 30 renal transplant recipients from endemic regions who presented with Visceral Leishmaniasis in the post-transplantation period. Results: In this study, Visceral Leishmaniasis was more frequent in men (80%); the mean age of presentation was 40±10.5 years. The majority (66.7%) of patients worked in urban areas. Most of the patients (90%) cohabitated with domestic animals and were from low-income households. In 73.3% of cases, diagnosis was made by direct isolation of Leishmania forms. The drug chosen for treatment was liposomal amphotericin, resulting in a high degree of disease remission (80%). Conclusion: This study describes the largest series of Visceral Leishmaniasis in renal transplant recipients and expands clinical-epidemiological knowledge for transplantation teams to perform adequate disease management for this specific patient population
- Published
- 2014
- Full Text
- View/download PDF
10. Effect of bee pollen on the immunity and tibia characteristics in broilers
- Author
-
Oliveira, MC de, Silva, DM da, Loch, FC, Martins, PC, Dias, DMB, and Simon, GA
- Subjects
lymphoid organs ,bee products ,Antibodies - Abstract
This study was carried out to evaluate the effect of bee pollen (BP) levels on the IgG and IgM titers, weight of lymphoid organs, and on the tibia morphometric measures and mineralization in broilers at 21 and 42 days of age. Four hundred birds were used in an entirely randomized design with four treatments (0, 0.5, 1 and 1.5% of BP feed inclusion) and five replicates. At 21 and 42 days of rearing, blood samples were collected for IgG and IgM analysis, as well as lymphoid organs (bursa, thymus and spleen) and the tibiae. There was no effect (p>0.05) of the BP inclusion on IgG titers, bursa and spleen weights, tibia morphometric measures and mineralization at 21 and 42 days, IgM titer at 42 days or thymus weight at 21 days. However, IgM titers at 21 days and the thymus weight at 42 days linearly increased with BP dietary inclusion. It was concluded that up to 1.5% BP can be included in broiler feeds until 21 days of age to enhance bird immunity.
- Published
- 2013
11. Effect of bee pollen on the immunity and tibia characteristics in broilers
- Author
-
Oliveira, MC de, primary, Silva, DM da, additional, Loch, FC, additional, Martins, PC, additional, Dias, DMB, additional, and Simon, GA, additional
- Published
- 2013
- Full Text
- View/download PDF
12. PL.91 The Ethics Decision Concerning Premature Newborn: Reflections of Doctors and Nurses
- Author
-
Silva, EMB, primary and Silva, DM, additional
- Published
- 2013
- Full Text
- View/download PDF
13. Genome sequences of four novel Endozoicomonas strains associated with a tropical octocoral in a long-term aquarium facility.
- Author
-
Marques M, da Silva DM, Santos E, Baylina N, Peixoto R, Kyrpides NC, Woyke T, Whitman WB, Keller-Costa T, and Costa R
- Abstract
We report the genome sequences of four Endozoicomonas sp. strains isolated from the octocoral Litophyton maintained long term at an aquarium facility. Our analysis reveals the coding potential for versatile polysaccharide metabolism; Type II, III, IV, and VI secretion systems; and the biosynthesis of novel ribosomally synthesized and post-translationally modified peptides.
- Published
- 2024
- Full Text
- View/download PDF
14. Encapsulation, Shelf Life, and Virulence of Batkoa sp. Against Dalbulus maidis .
- Author
-
Silva DM, Iwanicki NSA, Muskat LC, Patel AV, and Delalibera Júnior I
- Abstract
Batkoa is a genus of entomophthoralean fungi often associated with insect epizootics, particularly in phytophagous hemipterans. Encapsulation has become a promising strategy for improving the shelf life and sporulation of these fungi post-application. This study aims to (i) compare the virulence of the submerged propagules and primary conidia of Batkoa sp. ESALQ1199 against Dalbulus maidis ; (ii) formulate submerged propagules in calcium alginate beads with co-formulants; (iii) assess the colony-forming units and sporulation of encapsulated beads dried with different kaolin concentrations (0%, 2%, 4%, 8% and 10%); (iv) determine the shelf life of dried bead formulations containing 10% kaolin, comparing washed and unwashed beads treated with a 4% sucrose solution; and (v) assess the sporulation capacity of beads with 10% kaolin, washed and unwashed with 4% sucrose solution, over time under humid conditions. Our results demonstrated that primary conidia and submerged propagules effectively killed 82.4% and 57.8% of adult corn leafhoppers, respectively. Co-formulants maintained viability above 80% in dried propagules, while control samples dropped to 45%, indicating the sensitivity of submerged propagules to the drying process. Encapsulated Batkoa sp. retained the same concentration of viable propagules per bead and the number of conidia produced (sporulation) for 30 days at 28 °C. The sporulation of fresh beads increased during the incubation period, plateauing after 27 days. This suggests that Batkoa sp. beads can produce primary conidia under humid field conditions, serving as a potential inoculum source for new infections.
- Published
- 2024
- Full Text
- View/download PDF
15. Plasma Surface Modification of the Inner Wall of Montgomery's Tracheal Implant (T-Tube).
- Author
-
Kostov KG, Barbosa AA, do Nascimento F, Cardoso PFG, Almeida ACPL, Quade A, Legendre D, Hein LRO, Silva DM, and Koga-Ito CY
- Abstract
Tracheal stenosis (i.e., the abnormal narrowing of the trachea) can occur due to a variety of inflammatory and infectious processes as well as due to therapeutic procedures undertaken by the patient. The most common cause of tracheal obstruction in patients has been prolonged intubation. Depending on the extent of the stenosis and its exact location, the surgical insertion of a tracheal stent is the only option for addressing this issue. The Montgomery T-tube implant is a valuable tracheal stent made from medical-grade silicone that provides a functional airway while supporting the tracheal mucosa. However, its performance is subject to gradual deterioration due to biofilm colonization of the stent's inner wall, which may explain the discomfort claimed by many patients and clinical failures. Recently, cold atmospheric plasmas (CAPs) have emerged as an alternative technology to many conventional medical procedures, such as wound healing, skin treatment, decontamination of medical devices, etc. Here, we report on plasma-induced surface modification of the inner wall of a T-tube implant, considering future biomedical applications. To generate the plasma, we employed a cold atmospheric pressure plasma jet in gas helium, which was directly inserted into the T-tube implant. To assess the treatment uniformity, the degree of surface modification and its extension along the stent's inner wall was analyzed using different process parameters.
- Published
- 2024
- Full Text
- View/download PDF
16. Sleep disorders and risk of alzheimer's disease: A two-way road.
- Author
-
Lacerda RAV, Desio JAF, Kammers CM, Henkes S, Freitas de Sá M, de Souza EF, da Silva DM, Teixeira Pinheiro Gusmão C, and Santos JCCD
- Subjects
- Humans, Risk Factors, Sleep physiology, Homeostasis physiology, Animals, Alzheimer Disease physiopathology, Alzheimer Disease metabolism, Sleep Wake Disorders physiopathology, Sleep Wake Disorders complications
- Abstract
Substantial sleep impairment in patients with Alzheimer's disease (AD) is one of the emerging points for continued efforts to better understand the disease. Individuals without cognitive decline, an important marker of the clinical phase of AD, may show early alterations in the sleep-wake cycle. The objective of this critical narrative review is to explore the bidirectional pathophysiological correlation between sleep disturbances and Alzheimer's Disease. Specifically, it examines how the disruption of sleep homeostasis in individuals without dementia could contribute to the pathogenesis of AD, and conversely, how neurodegeneration in individuals with Alzheimer's Disease might lead to dysregulation of the sleep-wake cycle. Recent scientific results indicate that sleep disturbances, particularly those related to impaired glymphatic clearance, may act as an important mechanism associated with the genesis of Alzheimer's Disease. Additionally, amyloid deposition and tau protein hyperphosphorylation, along with astrocytic hyperactivation, appear to trigger changes in neurotransmission dynamics in areas related to sleep, which may explain the onset of sleep disturbances in individuals with AD. Disruption of sleep homeostasis appears to be a modifiable risk factor in Alzheimer's disease. Whenever possible, the use of non-pharmacological strategies becomes important in this context. From a different perspective, additional research is needed to understand and treat the dysfunction of the sleep-wake cycle in individuals already affected by AD. Early recognition and correction of sleep disturbances in this population could potentially mitigate the progression of dementia and improve the quality of life for those with AD., Competing Interests: Declaration of Competing Interest The authors declare that they have no conflicts of interest. All authors read and approved the final manuscript., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
17. Penicillium citrinum CFAM 521 Isolated From the Amazon Region: A Novel Source of a Fibrinolytic Enzyme.
- Author
-
de Souza TC, Schwarz MGA, da Silva DM, Maia CR, de Araújo CPM, Balieiro AADS, de Oliveira LA, Degrave WMS, Fernandes OCC, and Mendonça-Lima L
- Abstract
Fibrinolytic agents are essential in treating thrombosis, playing a critical role in improving survival rates in cardiovascular diseases. Microbial fibrinolytic proteases have emerged as promising alternatives due to their affordability, specificity, lower toxicity, and reduced side effects. Consequently, the search for microorganisms capable of producing these enzymes has gained significant economic importance in the pharmaceutical industry. This study reports and characterizes a novel fibrinolytic enzyme produced by Penicillium citrinum CFAM 521, a strain isolated from the Amazon region. The enzyme was purified using a polyethylene glycol (PEG)-phosphate salt aqueous two-phase system (ATPS). The effects of PEG molecular weight, PEG concentration, and phosphate concentration on the protease partition coefficient (K) were evaluated through a 2
2 full factorial design. The enzyme exhibited both fibrinolytic and fibrinogenolytic activities. After partitioning in a two-phase system with 10% (w/w) PEG and 15% (w/w) sodium phosphate, the fibrinolytic proteases were predominantly retained in the salt-rich bottom phase ( K = 0.33). The enzyme has a molecular weight of 34 kDa, with optimal pH and temperature at 9°C and 37°C, respectively. Inhibitory analysis confirmed that it is a serine protease, and its activity was enhanced by the addition of Mn2+ . Notably, the enzyme exhibited no hemolytic activity. Therefore, P. citrinum CFAM 521 represents a novel source of fibrinolytic enzymes, highlighting its potential as an alternative for the development of thrombolytic agents., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2024 Thayana Cruz de Souza et al.)- Published
- 2024
- Full Text
- View/download PDF
18. Juvenile-related tolerance to papaya sticky disease (PSD): proteomic, ultrastructural, and physiological events.
- Author
-
Rodrigues SP, de A Soares E, Antunes TFS, Maurastoni M, Madroñero LJ, Broetto SG, Nunes LEC, Verçoza BRF, Buss DS, Silva DM, Rodrigues JCF, Ventura JA, and Fernandes PMB
- Subjects
- Photosynthesis, Plant Leaves metabolism, Plant Leaves virology, Gene Expression Regulation, Plant, Proteome metabolism, Plant Viruses physiology, Disease Resistance, Carica virology, Carica metabolism, Plant Diseases virology, Proteomics methods, Plant Proteins metabolism, Plant Proteins genetics, Cell Wall metabolism, Cell Wall ultrastructure
- Abstract
Key Message: The proteomic analysis of PMeV-complex-infected C. papaya unveiled proteins undergoing modulation during the plant's development. The infection notably impacted processes related to photosynthesis and cell wall dynamics. The development of Papaya Sticky Disease (PSD), caused by the papaya meleira virus complex (PMeV-complex), occurs only after the juvenile/adult transition of Carica papaya plants, indicating the presence of tolerance mechanisms during the juvenile development phase. In this study, we quantified 1609 leaf proteins of C. papaya using a label-free strategy. A total of 345 differentially accumulated proteins were identified-38 at 3 months (juvenile), 130 at 4 months (juvenile/adult transition), 160 at 7 months (fruit development), and 17 at 9 months (fruit harvesting)-indicating modulation of biological processes at each developmental phase, primarily related to photosynthesis and cell wall remodeling. Infected 3- and 4-mpg C. papaya exhibited an accumulation of photosynthetic proteins, and chlorophyll fluorescence results suggested enhanced energy flux efficiency in photosystems II and I in these plants. Additionally, 3 and 4-mpg plants showed a reduction in cell wall-degrading enzymes, followed by an accumulation of proteins involved in the synthesis of wall precursors during the 7 and 9-mpg phases. These findings, along with ultrastructural data on laticifers, indicate that C. papaya struggles to maintain the integrity of laticifer walls, ultimately failing to do so after the 4-mpg phase, leading to latex exudation. This supports initiatives for the genetic improvement of C. papaya to enhance resistance against the PMeV-complex., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
19. Phytochemical and antimicrobial evaluation of Miconia burchellii Triana (Melastomataceae).
- Author
-
Cunha GOS, Pinto OG, da Silva DM, Dos Santos ML, and Menezes ACS
- Abstract
Four novel triterpenoid saponins, 1 α ,3 β ,23-trihydroxy-olean-12-en-28-oic acid 28- O - β -glycopyranoside ester ( 1 ), 1 α ,3 β ,23-trihydroxy-urs-12-en-28-oic acid 28- O - β -glycopyranoside ester ( 2 ), 3- O - β -galloyl-1 α ,23-dihydroxy-olean-12-en-28-oic acid 28- O - β -glycopyranoside ester ( 3 ) and 3- O - β -galloyl-1 α ,23-dihydroxy-urs-12-en-28-oic acid 28- O - β -glycopyranoside ester ( 4 ) and two new pentacyclic triterpenoids, 3- O - β - trans - p -coumaroyl-1 α -hydroxy-urs-12-en-28-oic acid ( 5 ) and 3- O - β - cis - p -coumaroyl-1 α -hydroxy-urs-12-en-28-oic acid ( 6 ), together with six known compounds were isolated from the ethanolic extracts of Miconia burchellii leaves and stem bark. Their structures were established by HR-MS, 1D and 2D NMR and comparison with literature data. Additionally, the antimicrobial activity of the leaves and stem bark extracts and fractions was evaluated using the micro broth dilution technique. The crude extract, the ethyl acetate and methanol fractions of the stem bark were the most active against the tested bacteria, showing growth inhibition of both Gram-positive ( Staphylococcus aureus and Staphylococcus epidermidis ) and Gram-negative ( Escherichia coli and Pseudomonas aeruginosa ). To the best of our knowledge, this is the first study to report on the antimicrobial activity of M. burchellii.
- Published
- 2024
- Full Text
- View/download PDF
20. Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer.
- Author
-
Tsimberidou AM, Alayli FA, Okrah K, Drakaki A, Khalil DN, Kummar S, Khan SA, Hodi FS, Oh DY, Cabanski CR, Gautam S, Meier SL, Amouzgar M, Pfeiffer SM, Kageyama R, Yang E, Spasic M, Tetzlaff MT, Foo WC, Hollmann TJ, Li Y, Adamow M, Wong P, Moore JS, Velichko S, Chen RO, Kumar D, Bucktrout S, Ibrahim R, Dugan U, Salvador L, Hubbard-Lucey VM, O'Donnell-Tormey J, Santulli-Marotto S, Butterfield LH, Da Silva DM, Fairchild J, LaVallee TM, Padrón LJ, and Sharma P
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Immune Checkpoint Inhibitors therapeutic use, Immune Checkpoint Inhibitors pharmacology, Neoplasm Metastasis, Neoplasms drug therapy, Neoplasms immunology, Neoplasms pathology, Tumor Microenvironment immunology, CD8-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes drug effects, Drug Resistance, Neoplasm, Ipilimumab therapeutic use, Nivolumab therapeutic use, Nivolumab administration & dosage
- Abstract
Identifying pan-tumor biomarkers that predict responses to immune checkpoint inhibitors (ICI) is critically needed. In the AMADEUS clinical trial (NCT03651271), patients with various advanced solid tumors were assessed for changes in intratumoral CD8 percentages and their response to ICI. Patients were grouped based on tumoral CD8 levels: those with CD8 <15% (CD8-low) received nivolumab (anti-PD-1) plus ipilimumab (anti-CTLA4) and those with CD8 ≥15% (CD8-high) received nivolumab monotherapy. 79 patients (72 CD8-low and 7 CD8-high) were treated. The disease control rate was 25.0% (18/72; 95% CI: 15.8-35.2) in CD8-low and 14.3% (1/7; 95% CI: 1.1-43.8) in CD8-high. Tumors from 35.9% (14/39; 95% CI: 21.8-51.4) of patients converted from CD8 <15% pretreatment to ≥15% after treatment. Multiomic analyses showed that CD8-low responders had an inflammatory tumor microenvironment pretreatment, enhanced by an influx of CD8 T cells, CD4 T cells, B cells, and macrophages upon treatment. These findings reveal crucial pan-cancer immunological features for ICI response in patients with metastatic disease., (© 2024 Tsimberidou et al.)
- Published
- 2024
- Full Text
- View/download PDF
21. Anti-Inflammatory Activity and Acute Toxicity Of Pereskia aculeata, In Zophobas morio Larvae.
- Author
-
E Silva DM, Nunes LGA, Prado da Silva N, de Freitas PHS, Scio E, Tavares GD, Almeida Alves I, and de Carvalho da Costa J
- Subjects
- Animals, Mice, Sitosterols pharmacology, Sitosterols chemistry, Cell Line, Phytosterols pharmacology, Phytosterols chemistry, Cell Survival drug effects, Dose-Response Relationship, Drug, Plant Extracts chemistry, Plant Extracts pharmacology, Plant Extracts isolation & purification, Larva drug effects, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents chemistry, Anti-Inflammatory Agents isolation & purification, Stigmasterol pharmacology, Stigmasterol chemistry, Stigmasterol isolation & purification, Nitric Oxide metabolism, Nitric Oxide antagonists & inhibitors
- Abstract
Pereskia aculeata has been widely investigated due to its anti-inflammatory potential. Among the metabolites found in this species are the phytosterols beta-sitosterol (β-SIT) and stigmasterol (STIG). The objective of the study was to evaluate the anti-inflammatory and toxicity activities of the hexane partition of P. aculeata (PHEX), as well as β-SIT and STIG. PHEX was prepared and the phytosterols were quantified. In terms of toxicity against L929 fibroblast cells, PHEX showed toxicity up to 200 μg/mL; STIG and β-SIT showed toxicity up to 25 μg/mL. PHEX inhibited 66 % of nitric oxide radicals, while STIG and β-SIT inhibited 33.73 % and 34.94 %, respectively. In an anti-inflammatory test against Zophobas morio larvae, all samples significantly reduced hemocyte levels. Additionally, the LD50 values were calculated: 229.6 mg/kg for PHEX, 101.5 mg/kg for STIG, and 103.8 mg/kg for β-SIT. In conclusion, the study indicates that the phytosterols present in PHEX may contribute to its anti-inflammatory activity., (© 2024 Wiley-VHCA AG, Zurich, Switzerland.)
- Published
- 2024
- Full Text
- View/download PDF
22. Uncovering microplastics contamination in canned seafood.
- Author
-
Silva DM, Almeida CMR, Guardiola FA, Pereira R, Rodrigues SM, and Ramos S
- Subjects
- Animals, Food, Preserved analysis, Seafood analysis, Food Contamination analysis, Microplastics analysis
- Abstract
There is limited research on the occurrence of microplastics (MPs) in canned seafood. All types of canned seafood investigated in the present study were contaminated. After sample digestion in 30 % hydrogen peroxide, a total of 40 MPs were recovered. Fibers were the most common type, blue was the dominant colour, and Fourier Transform Infrared Spectroscopy (FTIR) identified polyester as the most common polymer. Considering all samples, an average of 3.5 ± 5.2 MPs/can was obtained, with octopus in tomato sauce and tuna in olive oil presenting the highest contamination (5.2 ± 7.5 MPs/can and 5.2 ± 5.1 MPs/can, respectively). Also, significant differences between the number of MPs in the seafood tissues and immersion liquids were verified. The present study demonstrates MPs occurrence in canned seafood, a potential contamination pathway for humans. More research on the different stages of the canning processing is vital for understanding MPs contamination in cans., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
23. Estimation of economic losses due to leptospirosis in dairy cattle.
- Author
-
Carvalho HGAC, Silva DM, Rodrigues GRD, Gameiro AH, Dos Santos RF, Raineri C, and Lima AMC
- Subjects
- Animals, Cattle, Female, Prevalence, Disease Outbreaks veterinary, Disease Outbreaks prevention & control, Leptospira, Leptospirosis veterinary, Leptospirosis epidemiology, Leptospirosis prevention & control, Leptospirosis economics, Cattle Diseases economics, Cattle Diseases epidemiology, Cattle Diseases prevention & control, Cattle Diseases microbiology, Dairying economics
- Abstract
There are few studies that effectively quantify the economic losses resulting from problems caused by leptospirosis in naturally infected dairy cattle. Given this gap, the objective of this study was to propose and apply a method to quantify the economic losses resulting from productive and reproductive problems in a commercial dairy herd naturally infected by Leptospira spp. For this study, the zootechnical and economic indicators at a property with Jersey cattle were analyzed during the period from 2014 to 2017. The leptospirosis outbreak occurred in 2014, and the therapeutic approach was carried out between 2015 and 2017, with the latter considered the year of control of the outbreak. The adopted integrated control strategy consisted of dividing the herd according to the serological results obtained through the microscopic agglutination test, the treatment of reagents with streptomycin, and vaccination against leptospirosis of non-reagent heifers and cows. The method used to evaluate the economic indicators of the property was the calculation of the gross margin by taking into account the implicit and explicit cost parameters associated with the manifestation of leptospirosis. The prevalence rate of leptospirosis decreased from 49.4 % in 2015 to 21.6 % in 2017. There was a reduction in the abortion rate (from 40.00 % in 2014 to 9.00 % in 2017), in the stillborn rate (from 2.63 % in 2014 to 1.69 % in 2017) and an increase in the calving rate (from 65.00 % in 2014 to 86.00 % in 2017). In addition, there were increases in the number of lactating cows (from 38 in 2014-57 in 2017) and the mean times of lactation duration, which increased from 275 days in 2014-295 days in 2017. As a result, the average annual production of milk increased from 164,655 liters in 2014-248,521 liters in 2017. In 2014, when treatment hadn't yet started, the gross margin per liter of milk sold, considering implicit and explicit costs, was US$0.00. In 2015 and 2016, US$0.27 and US$0.30 were obtained, respectively, for this variable. In 2017, with the disease under control on the property, the gross margin per liter of milk reached US$0.36. The gross margin per liter of milk sold was higher in the period when the disease was controlled, showing losses of up to 84 % of the gross margin during the outbreak. Immediate treatment of positive cows and preventive measures had a significant impact on improving the productive and economic efficiency of the property., Competing Interests: Declaration of Competing Interest The authors have no conflicts of interest., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
24. Advancing nursing education in Brazil: A systematic literature review of curricular evolution and emerging challenges.
- Author
-
da Veiga CRP, de Moraes ALL, Marques VG, da Silva DM, and da Veiga CP
- Subjects
- Brazil, Humans, Education, Nursing trends, Curriculum trends
- Abstract
Objective: This study assesses changes and challenges within the nursing curriculum in the Brazilian context, focusing on addressing contemporary professional and societal demands., Design: A systematic literature review (SLR) was conducted to identify and analyze the changes in Brazil's nursing curricula over time., Data Sources: Articles published between 1987 and 2023 were selected from Scopus and Web of Science databases for the systematic review., Review Methods: A hybrid review approach was employed, integrating Systematic Literature Review (SLR), Bibliometrics, and metanarrative. The study adhered to the SPAR-4-SLR (Scientific Procedures and Rationale for Systematic Literature Reviews) protocol, involving three main stages: (i) aggregation, (ii) organization, and (iii) evaluation. The analysis primarily focused on identifying emerging trends and evaluating curricular changes over the specified timeframe., Results: Analysis of the selected literature identified four principal thematic groups that emerged during the review period: (i) longitudinal curriculum assessment, (ii) biological and health sciences, (iii) human and social sciences, and (iv) nursing sciences. Noteworthy trends included the integration of emerging topics like mental health and care for victims of violence, coupled with a notable increase in emphasis on transformative and competency-based education. Nevertheless, significant gaps were observed in the existing literature, particularly concerning the absence of perspectives from students and recent graduates and limited research on vulnerabilities within the curriculum structure., Conclusions: This study underscores the imperative for flexible and adaptable nursing curricula that effectively address Brazil's diverse regional and social realities. It emphasizes the significance of adopting a holistic and inclusive approach to nursing education, preparing professionals to confront contemporary health challenges in a nation characterized by extensive cultural diversity and vast geographical dimensions. Further research and input from students and recent graduates are indispensable to rectify the gaps and ensure the continuous evolution of nursing education in Brazil., Competing Interests: Declaration of competing interest The authors declare that they have no competing interests or personal relationships that could influence the findings reported in this paper. Hence, the authors declare that they have no conflict of interest., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
25. Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma.
- Author
-
Till JE, McDaniel L, Chang C, Long Q, Pfeiffer SM, Lyman JP, Padrón LJ, Maurer DM, Yu JX, Spencer CN, Gherardini PF, Da Silva DM, LaVallee TM, Abbott C, Chen RO, Boyle SM, Bhagwat N, Cannas S, Sagreiya H, Li W, Yee SS, Abdalla A, Wang Z, Yin M, Ballinger D, Wissel P, Eads J, Karasic T, Schneider C, O'Dwyer P, Teitelbaum U, Reiss KA, Rahma OE, Fisher GA, Ko AH, Wainberg ZA, Wolff RA, O'Reilly EM, O'Hara MH, Cabanski CR, Vonderheide RH, and Carpenter EL
- Subjects
- Humans, Female, Male, Middle Aged, Aged, Prognosis, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Mutation, Progression-Free Survival, Neoplasm Metastasis, Carcinoma, Pancreatic Ductal genetics, Carcinoma, Pancreatic Ductal mortality, Carcinoma, Pancreatic Ductal blood, Carcinoma, Pancreatic Ductal pathology, Carcinoma, Pancreatic Ductal drug therapy, Proto-Oncogene Proteins p21(ras) genetics, Pancreatic Neoplasms genetics, Pancreatic Neoplasms blood, Pancreatic Neoplasms mortality, Pancreatic Neoplasms pathology, Pancreatic Neoplasms drug therapy, Circulating Tumor DNA blood, Circulating Tumor DNA genetics, Biomarkers, Tumor blood, Biomarkers, Tumor genetics
- Abstract
While high circulating tumor DNA (ctDNA) levels are associated with poor survival for multiple cancers, variant-specific differences in the association of ctDNA levels and survival have not been examined. Here we investigate KRAS ctDNA (ctKRAS) variant-specific associations with overall and progression-free survival (OS/PFS) in first-line metastatic pancreatic ductal adenocarcinoma (mPDAC) for patients receiving chemoimmunotherapy ("PRINCE", NCT03214250), and an independent cohort receiving standard of care (SOC) chemotherapy. For PRINCE, higher baseline plasma levels are associated with worse OS for ctKRAS G12D (log-rank p = 0.0010) but not G12V (p = 0.7101), even with adjustment for clinical covariates. Early, on-therapy clearance of G12D (p = 0.0002), but not G12V (p = 0.4058), strongly associates with OS for PRINCE. Similar results are obtained for the SOC cohort, and for PFS in both cohorts. These results suggest ctKRAS G12D but not G12V as a promising prognostic biomarker for mPDAC and that G12D clearance could also serve as an early biomarker of response., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
26. New parameters for in vitro development of cell lines of the species Astyanax bimaculatus (Linnaeus, 1758) and Geophagus proximus (Castelnau, 1855).
- Author
-
de Oliveira Furo I, Nogueira LS, de Sousa RPC, Silva-Oliveira GC, Dos Santos da Silva DM, Costa-Malaquias A, and de Oliveira EHC
- Subjects
- Animals, Cell Line, Cell Proliferation, Animal Fins cytology, Characidae growth & development, Cell Culture Techniques, Culture Media
- Abstract
Intending to compare in vitro cell growth in different conditions, we established cell cultures using fin biopsies of two freshwater fishes, Astyanax bimaculatus and Geophagus proximus. Three different culture media (Leibovitz-L-15, Dulbecco's Modified Eagle Medium [DMEM], and 199) were employed, with or without the addition of AmnioMax, maintaining a standard temperature of 29°C. Based on the results obtained, we standardized a cell growth protocol in which medium 199 was less efficient for both species. Notably, G. proximus cells exhibited superior proliferation in DMEM and L-15 media, whereas A. bimaculatus cells demonstrated better parameters exclusively in the DMEM medium. Successful subculturing of cells with good proliferation index was observed, accompanied by preserved morphological characteristics. Therefore, the methodology outlined in this study represents an advancement in establishing fish cell cultures., (© 2024 Fisheries Society of the British Isles.)
- Published
- 2024
- Full Text
- View/download PDF
27. Spheroid Model of Mammary Tumor Cells: Epithelial-Mesenchymal Transition and Doxorubicin Response.
- Author
-
Coelho LL, Vianna MM, da Silva DM, Gonzaga BMS, Ferreira RR, Monteiro AC, Bonomo AC, Manso PPA, de Carvalho MA, Vargas FR, and Garzoni LR
- Abstract
Breast cancer is the most prevalent cancer among women worldwide. Therapeutic strategies to control tumors and metastasis are still challenging. Three-dimensional (3D) spheroid-type systems more accurately replicate the features of tumors in vivo, working as a better platform for performing therapeutic response analysis. This work aimed to characterize the epithelial-mesenchymal transition and doxorubicin (dox) response in a mammary tumor spheroid (MTS) model. We evaluated the doxorubicin treatment effect on MCF-7 spheroid diameter, cell viability, death, migration and proteins involved in the epithelial-mesenchymal transition (EMT) process. Spheroids were also produced from tumors formed from 4T1 and 67NR cell lines. MTSs mimicked avascular tumor characteristics, exhibited adherens junction proteins and independently produced their own extracellular matrix. Our spheroid model supports the 3D culturing of cells isolated from mice mammary tumors. Through the migration assay, we verified a reduction in E-cadherin expression and an increase in vimentin expression as the cells became more distant from spheroids. Dox promoted cytotoxicity in MTSs and inhibited cell migration and the EMT process. These results suggest, for the first time, that this model reproduces aspects of the EMT process and describes the potential of dox in inhibiting the metastatic process, which can be further explored.
- Published
- 2024
- Full Text
- View/download PDF
28. Self-Perceived Vocal Symptoms and Discomfort in Amateur Church Singers.
- Author
-
da Silva DM, de Lacerda MM, Depolli GT, Azevedo EHM, Moreti F, and Guimarães MF
- Abstract
Purpose: To analyze self-perceived vocal symptoms and discomfort in amateur church singers and compare them between genders and church types., Methods: It was a quantitative cross-sectional study involving 99 amateur church singers aged between 18 and 59years. Data collection was carried out through the completion of a sociodemographic questionnaire, the Voice Symptom Scale (VoiSS), and the Vocal Tract Discomfort Scale (VTDS). The Mann-Whitney test was used for comparisons, and Spearman's correlation test was used for analyzing correlations between scale scores. The adopted significance level was 5% (P < 0.05)., Results: There was a prevalence of females (71.7%), amateur singers from Protestant churches (73.7%), with a mean age of 27.5years. The average VoiSS total score was 22.6 points, the "limitation" domain was 12.3, the "emotional" domain was 2.55, and the "physical" domain was 7.7. The most self-perceived sensations in the VTDS were "dryness," "sore throat," and "itchiness" with mild to moderate intensity. There was a statistically significant difference between genders (P < 0.05) and a positive correlation from weak (r = 0.212) to strong magnitude (r = 0.660) between vocal symptoms and vocal tract discomfort. There was no statistically significant difference between types of churches., Conclusion: Amateur singers self-report high levels of vocal symptoms, which impact limitation, emotional, and physical domains. Furthermore, they experience vocal tract discomfort sensations, with dryness being the most frequently reported, followed by sore throat and itching. No significant differences were found between the scale scores and church types. However, females reported a greater frequency and intensity of vocal tract discomfort sensations. The greater the self-reported vocal symptoms in this population, the higher their self-reported frequency and intensity of vocal tract discomfort sensations. These findings underscore the importance of addressing vocal health issues in amateur singers to enhance their overall well-being., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Voice Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
29. Germline genetic regulation of the colorectal tumor immune microenvironment.
- Author
-
Schmit SL, Tsai YY, Bonner JD, Sanz-Pamplona R, Joshi AD, Ugai T, Lindsey SS, Melas M, McDonnell KJ, Idos GE, Walker CP, Qu C, Kast WM, Da Silva DM, Glickman JN, Chan AT, Giannakis M, Nowak JA, Rennert HS, Robins HS, Ogino S, Greenson JK, Moreno V, Rennert G, and Gruber SB
- Subjects
- Humans, Male, Female, Middle Aged, Quantitative Trait Loci, Aged, Lymphocytes, Tumor-Infiltrating immunology, Germ-Line Mutation, RNA-Binding Proteins genetics, Genotype, Germ Cells metabolism, Colorectal Neoplasms genetics, Colorectal Neoplasms immunology, Tumor Microenvironment genetics, Tumor Microenvironment immunology, Polymorphism, Single Nucleotide, Genome-Wide Association Study
- Abstract
Objective: To evaluate the contribution of germline genetics to regulating the briskness and diversity of T cell responses in CRC, we conducted a genome-wide association study to examine the associations between germline genetic variation and quantitative measures of T cell landscapes in 2,876 colorectal tumors from participants in the Molecular Epidemiology of Colorectal Cancer Study (MECC)., Methods: Germline DNA samples were genotyped and imputed using genome-wide arrays. Tumor DNA samples were extracted from paraffin blocks, and T cell receptor clonality and abundance were quantified by immunoSEQ (Adaptive Biotechnologies, Seattle, WA). Tumor infiltrating lymphocytes per high powered field (TILs/hpf) were scored by a gastrointestinal pathologist. Regression models were used to evaluate the associations between each variant and the three T-cell features, adjusting for sex, age, genotyping platform, and global ancestry. Three independent datasets were used for replication., Results: We identified a SNP (rs4918567) near RBM20 associated with clonality at a genome-wide significant threshold of 5 × 10
- 8 , with a consistent direction of association in both discovery and replication datasets. Expression quantitative trait (eQTL) analyses and in silico functional annotation for these loci provided insights into potential functional roles, including a statistically significant eQTL between the T allele at rs4918567 and higher expression of ADRA2A (P = 0.012) in healthy colon mucosa., Conclusions: Our study suggests that germline genetic variation is associated with the quantity and diversity of adaptive immune responses in CRC. Further studies are warranted to replicate these findings in additional samples and to investigate functional genomic mechanisms., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
30. Biocompatible adipose extracellular matrix and reduced graphene oxide nanocomposite for tissue engineering applications.
- Author
-
Verstappen K, Klymov A, Cicuéndez M, da Silva DM, Barroca N, Fernández-San-Argimiro FJ, Madarieta I, Casarrubios L, Feito MJ, Diez-Orejas R, Ferreira R, Leeuwenburgh SCG, Portolés MT, Marques PAAP, and Walboomers XF
- Abstract
Despite the immense need for effective treatment of spinal cord injury (SCI), no successful repair strategy has yet been clinically implemented. Multifunctional biomaterials, based on porcine adipose tissue-derived extracellular matrix (adECM) and reduced graphene oxide (rGO), were recently shown to stimulate in vitro neural stem cell growth and differentiation. Nevertheless, their functional performance in clinically more relevant in vivo conditions remains largely unknown. Before clinical application of these adECM-rGO nanocomposites can be considered, a rigorous assessment of the cytotoxicity and biocompatibility of these biomaterials is required. For instance, xenogeneic adECM scaffolds could still harbour potential immunogenicity following decellularization. In addition, the toxicity of rGO has been studied before, yet often in experimental settings that do not bear relevance to regenerative medicine. Therefore, the present study aimed to assess both the in vitro as well as in vivo safety of adECM and adECM-rGO scaffolds. First, pulmonary, renal and hepato-cytotoxicity as well as macrophage polarization studies showed that scaffolds were benign in vitro . Then, a laminectomy was performed at the 10th thoracic vertebra, and scaffolds were implanted directly contacting the spinal cord. For a total duration of 6 weeks, animal welfare was not negatively affected. Histological analysis demonstrated the degradation of adECM scaffolds and subsequent tissue remodeling. Graphene-based scaffolds showed a very limited fibrous encapsulation, while rGO sheets were engulfed by foreign body giant cells. Furthermore, all scaffolds were infiltrated by macrophages, which were largely polarized towards a pro-regenerative phenotype. Lastly, organ-specific histopathology and biochemical analysis of blood did not reveal any adverse effects. In summary, both adECM and adECM-rGO implants were biocompatible upon laminectomy while establishing a pro-regenerative microenvironment, which justifies further research on their therapeutic potential for treatment of SCI., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
31. Electronarcosis of Nile tilapia (Oreochromis niloticus): Effects on Dynamic Physiological Balance and Meat Quality.
- Author
-
Godoy AC, da Silva DM, Bittencourt F, Fantini-Hoag L, Rodrigues ML, Rodrigues RB, Weiler KA, Neu DH, Pfrime FWD, and Signor A
- Abstract
Introduction: Electronarcosis is the most commonly used stunning method for large animals, but its consequences in tilapia still need to be evaluated. The aim of the study was to evaluate the application of electronarcosis in the pre-slaughter stunning of Nile tilapia (Oreochromis ni-loticus) and verify its effects on dynamic physiological balance and meat quality., Methods: Nile tilapia specimens, totaling 184, with an average weight of 247.08 37.04 g, were randomly distributed. Each fish was individually placed in a rectangular tank constituted by a voltage regulator and aluminum electrode. The behavior of the fish subjected to different expo-sure times (5, 10, 20, and 30 seconds) and electric currents (1.50, 3.00, 4.50, and 6.00 amperes) with alternating and continuous currents was evaluated. Subsequently, the quality of the chilled fillets was checked after slaughter over a period of 35 days. The longest stun time was achieved using an alternating current of 3.00, 4.50, and 6.00A for 30 seconds., Results: The fillet quality index (FQI) showed a high correlation with the storage time. In the first 15 days of storage, the fish stunned with different alternating currents maintained a higher MQI, meeting the meat quality standard when compared to fish slaughtered by ice stunning. The fish fillets obtained using different electrical currents showed a pH similar to the fish fillets stunned with ice., Conclusion: Therefore, electronarcosis can be applied in the slaughter of tilapia using al-ternating current between three and six amps for 30 seconds, with euthanasia time of 37 and 46 seconds, ensuring safety in the slaughter procedures in the industry, the quality of the meat, and the well-being of the animal., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2024
- Full Text
- View/download PDF
32. Case report: Arteriovenous graft for hemodialysis using abdominal vessels.
- Author
-
Filippo MG, Melo MFDGG, da Silva DM, Nunes MAJ, Chun JSS, Maia ABAP, Furtado ALM, Kimura LHS, and Alves HFA
- Subjects
- Humans, Time Factors, Renal Dialysis, Treatment Outcome, Arteriovenous Shunt, Surgical, Kidney Failure, Chronic therapy, Central Venous Catheters
- Abstract
The improvement of dialysis therapy and clinical support has increased the life expectancy of patients with end stage renal disease (ESRD) over the last years. However, in Brazil, the renal transplant rate cannot follow this growth. This fact, in association with the unavailability of adequate healthcare services in the country, substantially enlarges the use of dual lumen catheters and, consequently, access-related complications. The result is a high rate of patients with access failure, which brings a challenge: how to maintain dialysis in this group? This case report describes a non-conventional surgical approach to create a definite access using abdominal vessels, in an end stage vascular access patient., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
33. Effects of Choline Supplementation in Diets on Juvenile Pacu (Piaractus mesopotamicus): Productive Performance, Proximate Composition and Serum Lipid Level.
- Author
-
Godoy AC, Bittencourt F, Fantini-Hoag L, Honorato CA, da Silva DM, Signor A, Seno LO, Burbarelli MFC, Boscolo WR, and Neu DH
- Abstract
Introduction: Pacu (Piaractus mesopotamicus) is a Brazilian fish species of high commercial value and has emerged as one of the main species with potential for intensive farming. This study aimed to investigate the impact of choline supplementation on productive performance, visceral fat, hepatosomatic indices, proximate composition, serum biochemical profile, and liver coloration in juvenile pacu (Piaractus mesopotamicus)., Method: The 60-day experiment was conducted in the experimental hatchery of the Study Group of Aquaculture Management - GEMAq of the State University of West Paraná, Brazil. The completely randomized design consisted of five treatments with four replicates each. A total of 200 fish, with an average initial weight and length of 4.25 g and 5.97 cm, were distributed among 20 experimental hapas, resulting in a stocking density of 10 fish per experimental unit. Fish fed a choline-deficient diet exhibited the lowest values for final weight, weight gain, visceral fat, and hepatosomatic index. Conversely, in terms of proximate composition, fish fed choline-deficient diets had the highest moisture content but the lowest crude fat content. Triglyceride levels in juvenile pacu were significantly higher in groups fed diets containing choline (400 to 1200 mg kg-1 ). We also observed significant differences in the cyan color of the liver (P < 0.05). Notably, we observed significant differences in the cyan coloration of the liver (P < 0.05). Other parameters did not exhibit significant changes in response to varying choline levels in the diets., Result: Our study demonstrated that choline supplementation in P. mesopotamicus juveniles at an optimal concentration of 400 mg kg-1 significantly impacted growth, metabolism, productive performance, proximate composition, biochemical parameters, and liver color., Conclusion: These findings offer crucial guidance for aquaculture professionals, enabling them to enhance growth and health in P. mesopotamicus farming. Further research on choline's influence on lipid metabolism holds potential for more precise dietary recommendations, ultimately improving the efficiency and sustainability of aquaculture practices for this species., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2024
- Full Text
- View/download PDF
34. Different sleep patterns during the COVID-19 pandemic: association with mood, exercise and light exposure.
- Author
-
David MCMM, Vieira GR, de Lima Leôncio LM, Dos Santos Neves L, Bezerra CG, de Mattos MSB, Dos Santos NF, Antunes RB, Silva DM, Araújo JF, and de Matos RJB
- Subjects
- Humans, Female, Adolescent, Young Adult, Adult, Pandemics, Cross-Sectional Studies, Surveys and Questionnaires, Sleep, Exercise, COVID-19 epidemiology, Disorders of Excessive Somnolence epidemiology, Sleep Initiation and Maintenance Disorders
- Abstract
The aim was to evaluate the sleep-wake cycle pattern, mood, perceived stress and some behaviors, such as physical exercise and exposure to natural light of college students during the COVID-19 pandemic. This is a cross-sectional study conducted between June and August 2020 using an electronic form provided by Google. The sample consisted of undergraduate students aged between 18 and 30 years old and residents of the northeast region of Brazil. The students generally had sleepiness and poor sleep quality, high levels of anxiety, mild to moderate depressive symptoms and moderate perceived stress. Some of these aspects were worse in women. The college students showed three sleep patterns: one group had good sleep quality without excessive daytime sleepiness; another group had poor sleep quality, but no excessive daytime sleepiness; and a third group had high daytime sleepiness, and less expressive sleep quality impairment. Greater exposure to sunlight and practicing physical exercise predominated in individuals with better sleep quality, suggesting that they are protective factors. In addition, excessive daytime sleepiness and poor sleep quality were separately associated with higher anxiety, depression and stress perception levels, proving to be important aspects for care in order to favor mental health during the pandemic. In conclusion, it is suggested that the COVID-19 pandemic affected the sleep of college students in a heterogeneous way. The differentiated sleep patterns are associated with exposure to natural light and exercising.
- Published
- 2024
- Full Text
- View/download PDF
35. Diet as an epigenetic factor in inflammatory bowel disease.
- Author
-
Marangoni K, Dorneles G, da Silva DM, Pinto LP, Rossoni C, and Fernandes SA
- Subjects
- Humans, Diet adverse effects, Epigenesis, Genetic, Inflammatory Bowel Diseases, Malnutrition complications, Gastrointestinal Microbiome
- Abstract
Inflammatory bowel disease (IBD) has as a main characteristic the exacerbation of the immune system against enterocytes, compromising the individual's intestinal microbiota. This inflammatory cascade causes several nutritional deficiencies, which further compromise immunological functioning and, as a result, worsen the prognosis. This vicious cycle can be interrupted as the patient's dietary pattern meets their needs according to their clinical condition, acting directly on the inflammatory process of IBD through the interaction of food, intestinal microbiota, and epigenome. Specific nutritional intervention for IBD has a crucial role in preventing and managing disease activity. This review addresses epigenetic modifications through dietary compounds as a mechanism for modulating the intestinal microbiota of patients with IBD., Competing Interests: Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article., (©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
36. Nursing guidelines for caregivers of children with congenital heart disease after discharge: Integrative Review.
- Author
-
Machado Amazonas BA, Guerreiro Vieira da Silva DM, and de Souza Ribeiro MN
- Subjects
- Child, Humans, Caregivers, Patient Discharge, Heart Defects, Congenital, Nursing Care
- Abstract
Objective: To identify the nursing guidelines for caregivers of children with congenital heart disease (CHD) after hospital discharge., Methods: This is an integrative literature review of articles published between 2016 and 2022. In order to select the studies, the controlled descriptors "Nursing Care", "Nursing", "Heart Defects, Congenital", "Caregivers" and "Child" were used in four scientific databases - LILACS, SCIELO, PUBMED and BDENF., Results: The current integrative literature review analyzed 11 articles from the original sample. The main nursing care issues are those related to nutrition, oral health, leisure and physical activity, care with medication and the surgical wound, as well as the need to offer support to these children's families. The authors emphasize that nurses are present at various moments in a child's life, including at birth, but the approach to CHD is scarce in their basic training as nurses, as well as in their professional practice, and there is a shortage of continuing education proposals for the care of children with CHD., Conclusion: The study showed that nursing guidelines are focused on basic care and family support for these children. Lastly, this study highlighted the important role of nurses in terms of consolidating guidelines on the care needs of these children., Competing Interests: The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose., (Copyright� by the Universidad de Antioquia.)
- Published
- 2023
- Full Text
- View/download PDF
37. Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer.
- Author
-
Tsai YY, Qu C, Bonner JD, Sanz-Pamplona R, Lindsey SS, Melas M, McDonnell KJ, Idos GE, Walker CP, Tsang KK, Da Silva DM, Moratalla-Navarro F, Maoz A, Rennert HS, Kast WM, Greenson JK, Moreno V, Rennert G, Gruber SB, and Schmit SL
- Subjects
- Humans, Heterozygote, Gene Frequency, Histocompatibility Antigens Class II genetics, HLA Antigens, Receptors, Antigen, T-Cell genetics, Histocompatibility Antigens Class I genetics, Colorectal Neoplasms genetics
- Abstract
Objective: Reduced diversity at Human Leukocyte Antigen (HLA) loci may adversely affect the host's ability to recognize tumor neoantigens and subsequently increase disease burden. We hypothesized that increased heterozygosity at HLA loci is associated with a reduced risk of developing colorectal cancer (CRC)., Methods: We imputed HLA class I and II four-digit alleles using genotype data from a population-based study of 5,406 cases and 4,635 controls from the Molecular Epidemiology of Colorectal Cancer Study (MECC). Heterozygosity at each HLA locus and the number of heterozygous genotypes at HLA class -I ( A , B , and C ) and HLA class -II loci ( DQB1 , DRB1 , and DPB1 ) were quantified. Logistic regression analysis was used to estimate the risk of CRC associated with HLA heterozygosity. Individuals with homozygous genotypes for all loci served as the reference category, and the analyses were adjusted for sex, age, genotyping platform, and ancestry. Further, we investigated associations between HLA diversity and tumor-associated T cell repertoire features, as measured by tumor infiltrating lymphocytes (TILs; N=2,839) and immunosequencing (N=2,357)., Results: Individuals with all heterozygous genotypes at all three class I genes had a reduced odds of CRC (OR: 0.74; 95% CI: 0.56-0.97, p = 0.031). A similar association was observed for class II loci, with an OR of 0.75 (95% CI: 0.60-0.95, p = 0.016). For class-I and class-II combined, individuals with all heterozygous genotypes had significantly lower odds of developing CRC (OR: 0.66, 95% CI: 0.49-0.87, p = 0.004) than those with 0 or one heterozygous genotype. HLA class I and/or II diversity was associated with higher T cell receptor (TCR) abundance and lower TCR clonality, but results were not statistically significant., Conclusion: Our findings support a heterozygote advantage for the HLA class-I and -II loci, indicating an important role for HLA genetic variability in the etiology of CRC., Competing Interests: GI: receives/received research funding from Myriad Genetics and Laboratories. JG: consultant for Guardant Health. VM: owns stock in Aniling. SG: Co-founder of Brogent International LLC with equity. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Tsai, Qu, Bonner, Sanz-Pamplona, Lindsey, Melas, McDonnell, Idos, Walker, Tsang, Da Silva, Moratalla-Navarro, Maoz, Rennert, Kast, Greenson, Moreno, Rennert, Gruber and Schmit.)
- Published
- 2023
- Full Text
- View/download PDF
38. Apelin and Visfatin Expression in Placental Tissue in Women With Preeclampsia and Overweight/Obesity.
- Author
-
Braga APDSX, Silva DM, de Farias Lelis D, Farias RE, Paraíso AF, Santos SHS, Martins AMEBL, and Andrade JMO
- Subjects
- Female, Pregnancy, Humans, Infant, Newborn, Apelin metabolism, Placenta metabolism, Overweight, Nicotinamide Phosphoribosyltransferase metabolism, Cross-Sectional Studies, Cytokines, Obesity metabolism, RNA, Messenger metabolism, Pre-Eclampsia
- Abstract
Background: Preeclampsia (PE) is a multifunctional and multisystem disorder. Several factors favor the development of PE, including obesity. Cytokines are also expressed in the placenta, predisposing to local alterations that favor the development of distinct pathological processes, including PE. This study aimed to evaluate the apelin and visfatin mRNA expression in the placental tissue of women with preeclampsia and overweight/obesity and correlates with maternal and fetal variables., Methods: A cross-sectional analytical study was performed with 60 pregnant women and their newborns. Clinical, anthropometric, and laboratory variables were collected. Placental tissue samples were obtained, and the apelin and visfatin mRNA expression levels were assessed by qRT-PCR., Results: The main findings evidenced lower levels of apelin expression in overweight/obese women, accompanied by a negative correlation with BMI and pre-pregnancy weight; a higher expression of apelin was also observed in women with late PE and no personal history of PE. For visfatin levels, higher expression levels were observed in women with late PE and term delivery. Furthermore, a positive correlation was observed between visfatin levels and fetal anthropometric parameters, such as weight, length, and head circumference., Conclusion: Apelin levels were less expressed in overweight/obese women. Apelin and visfatin levels were correlated/associated with maternal-fetal variables.
- Published
- 2023
- Full Text
- View/download PDF
39. Is it possible to contain COVID-19 in a female prison in Brazil? A pilot study.
- Author
-
Dias Silva EE, Chaves de Jesus P, Macedo Moura PH, Rego Rodrigues da Silva DM, Teles Dos Santos R, Cabral-Marques O, Alves da Mota Santana L, and Borges LP
- Subjects
- Humans, Female, Prisons, Pilot Projects, Brazil epidemiology, COVID-19 epidemiology, Prisoners
- Published
- 2023
- Full Text
- View/download PDF
40. Volumetric Absorptive Microsampling in the Analysis of Endogenous Metabolites.
- Author
-
de Sá E Silva DM, Thaitumu M, Theodoridis G, Witting M, and Gika H
- Abstract
Volumetric absorptive microsampling (VAMS) has arisen as a relevant tool in biological analysis, offering simplified sampling procedures and enhanced stability. Most of the attention VAMS has received in the past decade has been from pharmaceutical research, with most of the published work employing VAMS targeting drugs or other exogenous compounds, such as toxins and pollutants. However, biomarker analysis by employing blood microsampling has high promise. Herein, a comprehensive review on the applicability of VAMS devices for the analysis of endogenous metabolites/biomarkers was performed. The study presents a full overview of the analysis process, incorporating all the steps in sample treatment and validation parameters. Overall, VAMS devices have proven to be reliable tools for the analysis of endogenous analytes with biological importance, often offering improved analyte stability in comparison with blood under ambient conditions as well as a convenient and straightforward sample acquisition model.
- Published
- 2023
- Full Text
- View/download PDF
41. Upper airway angle and glottic height: a prospective cohort to evaluate two new features for airway prediction.
- Author
-
de Carvalho CC, da Silva DM, Leite MS, and de Andrade LB
- Abstract
Background: Predicting difficult direct laryngoscopies remains challenging and improvements are needed in preoperative airway assessment. We conceived two new tests (the upper airway angle and the glottic height) and assessed their association with difficult direct laryngoscopies as well as their predictive performance., Methods: A prospective cohort was conducted with 211 patients undergoing general anesthesia for surgical procedures. We assessed the association between difficult laryngoscopies and modified Mallampati Test (MMT), Upper Lip Bite Test (ULBT), Mandibular Length (ML), Neck Circumference (NC), Mouth Opening (MO), Sternomental Distance (SMD), Thyromental Distance (TMD), Upper Airway Angle (UAA), and Glottic Height (GH). We also estimated their predictive values., Results: Difficult laryngoscopy was presented by 12 patients (5.7%). Six tests were significantly associated with difficult laryngoscopies and their area under the ROC curve, and 95% CIs were as follows: UAA = 88.82 (81.86-95.78); GH = 86.43 (72.67-100); ML = 83.75 (72.77-94.74); NC = 79.17 (64.98-93.36); MO = 65.58 (45.13-86.02); and MMT = 77.89 (68.37-87.41)., Conclusion: We have found two new features (the UAA and the GH) to be significantly associated with the occurrence of difficult direct laryngoscopies. They also presented the best predictive performance amongst the nine evaluated tests in our cohort of patients. We cannot ensure, however, these tests to be superior to other regularly used bedside tests based on our estimated 95% CIs., Competing Interests: Conflicts of interest The authors declare no conflicts of interest., (Copyright © 2022 Sociedade Brasileira de Anestesiologia. Published by Elsevier España S.L.U. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
42. Fruits as nutraceuticals: A review of the main fruits included in nutraceutical patents.
- Author
-
Mesa NC, Alves IA, Vilela FMP, E Silva DM, Forero LAP, Novoa DMA, and de Carvalho da Costa J
- Subjects
- Antioxidants, Vitamins, Amino Acids, Fruit, Dietary Supplements
- Abstract
Fruits have relevant usefulness in the elaboration of nutraceutical compositions and, as it is considered a "natural medicine", its market has been growing exponentially each year. Fruits, in general, contain a large source of phytochemicals, carbohydrates, vitamins, amino acids, peptides and antioxidants that are of interest to be prepared as nutraceuticals. The biological properties of its nutraceuticals can range from antioxidant, antidiabetic, antihypertensive, anti-Alzheimer, antiproliferative, antimicrobial, antibacterial, anti-inflammatory, among others. Furthermore, the need for innovative extraction methods and products reveals the importance of developing new nutraceutical compositions. This review was developed by searching patents of nutraceuticals from January 2015 until January 2022 in Espacenet, the search database of the European Patent Office (EPO). Of 215 patents related to nutraceuticals, 43% (92 patents) were including fruits, mainly berries. A great number of patents were focused on the treatment of metabolic diseases, representing 45% of the total patents. The principal patent applicant was the United States of America (US), with 52%. The patents were applied by researchers, industries, research centers and institutes. It is important to highlight that from 92 fruit nutraceutical patent applications reviewed, 13 already have their products available on the market., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
43. Meiotic drive of noncentromeric loci in mammalian meiosis II eggs.
- Author
-
Silva DM and Akera T
- Subjects
- Animals, Female, Germ Cells, Alleles, Mammals genetics, Centromere genetics, Meiosis genetics
- Abstract
The germline produces haploid gametes through a specialized cell division called meiosis. In general, homologous chromosomes from each parent segregate randomly to the daughter cells during meiosis, providing parental alleles with an equal chance of transmission. Meiotic drivers are selfish elements who cheat this process to increase their transmission rate. In female meiosis, selfish centromeres and noncentromeric drivers cheat by preferentially segregating to the egg cell. Selfish centromeres cheat in meiosis I (MI), while noncentromeric drivers can cheat in both meiosis I and meiosis II (MII). Here, we highlight recent advances on our understanding of the molecular mechanisms underlying these genetic cheating strategies, especially focusing on mammalian systems, and discuss new models of how noncentromeric selfish drivers can cheat in MII eggs., Competing Interests: Declaration of Competing Interest The authors declare no competing interests., (Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
44. Occurrence of serological reactions for Leptospira spp. in donkeys and mules from Minas Gerais, Brazil.
- Author
-
Pires BC, Dos Santos JBF, de Almeida Ferreira Dos Santos JP, Silva DM, Dos Reis TFM, Cuccato LP, Ciuffa AZ, Rezende LM, Ribeiro RAC, and Lima AMC
- Subjects
- Animals, Brazil epidemiology, Equidae, Creatinine, Agglutination Tests veterinary, Antibodies, Bacterial, Leptospira, Leptospirosis epidemiology, Leptospirosis veterinary
- Abstract
Research concerning leptospirosis in donkeys and mules has been neglected around the world. Therefore, the aim of this study was to investigate the epidemiological situation of the prevalence of anti-Leptospira spp. antibodies in donkeys and mules from the state of Minas Gerais, Brazil. Blood serum samples were collected from 180 animals (109 donkeys and 71 mules) in two rural properties from the state of Minas Gerais, Brazil, and then submitted to a microscopic agglutination test (MAT). Urea and creatinine values were also quantified. Epidemiological variables such as age, breeding system, contact with other animal species, source of water and food, vaccination against leptospirosis, presence of reproductive alterations, and rodent control were also investigated. From 180 samples collected, 39 (21.67%) showed positive results in the MAT, at a dilution ≥ 1:100. Some animals were reactive for more than one serovar. The serovar Tarassovi was the most frequent (14.07%), followed by Hardjo (11.85%) and Wolffi (11.11%). There was a statistically significant difference between animals from 0 to 3 years of age reactive in the MAT in comparison to the other age groups. Most of the animals had urea and creatinine concentrations within the acceptable reference limit; however, there was a significant increase in creatinine levels in some of the test animals. The studied properties showed differences in some epidemiological aspects such as vaccination of the animals, presence of reproductive problems in the herd, and rodent control. Such aspects pointed as risk factors that may influence the frequency of positive serological results in property 1. The present study demonstrated that the prevalence of leptospirosis in donkeys and mules is high and several serovars are being maintained by these animals, representing a potential public health risk., (© 2023. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2023
- Full Text
- View/download PDF
45. Diversity of Anal HPV and Non-HPV Sexually Transmitted Infections and Concordance with Genital Infections in HIV-Infected and HIV-Uninfected Women in the Tapajós Region, Amazon, Brazil.
- Author
-
Rodrigues LLS, Pilotto JH, Martinelli KG, Nicol AF, De Paula VS, Gheit T, Oliveira NSC, Silva-de-Jesus C, Sahasrabuddhe VV, Da Silva DM, Kast WM, Hardick J, Gaydos CA, and Morgado MG
- Subjects
- Humans, Female, Brazil epidemiology, Cross-Sectional Studies, Chlamydia trachomatis, Cervix Uteri, Neisseria gonorrhoeae, Prevalence, Papillomavirus Infections complications, Papillomavirus Infections epidemiology, Sexually Transmitted Diseases complications, Sexually Transmitted Diseases epidemiology, HIV Infections complications, HIV Infections epidemiology, Chlamydia Infections complications, Chlamydia Infections epidemiology
- Abstract
The aim of this study was to classify the diversity of anal HPV and non-HPV sexually transmitted infections (STIs) and compare the concordance between anal and genital infections in HIV-infected and uninfected women living in the Tapajós region, Amazon, Brazil. A cross-sectional study was performed with 112 HIV-uninfected and 41 HIV-infected nonindigenous women. Anal and cervical scrapings were collected and analyzed for HPV, Chlamydia trachomatis (CT) , Neisseria gonorrheae (NG), Trichomonas vaginalis (TV), Mycoplasma genitalium (MG), and Human alphaherpesvirus 2 (HSV-2). The Kappa test evaluated the concordance between anal and genital infections. The overall prevalence of anal HPV infection was 31.3% in HIV-uninfected and 97.6% in HIV-infected women. The most frequent anal high-risk HPV (hrHPV) types were HPV18 and HPV16 in HIV-uninfected women and HPV51, HPV59, HPV31, and HPV58 in HIV-infected women. Anal HPV75 Betapapillomavirus was also identified. Anal non-HPV STIs were identified in 13.0% of all participants. The concordance analysis was fair for CT, MG, and HSV-2, almost perfect agreement for NG, moderate for HPV, and variable for the most frequent anal hrHPV types. Thus, a high prevalence of anal HPV infection with moderate and fair concordance between anal and genital HPV and non-HPV STIs was observed in our study.
- Published
- 2023
- Full Text
- View/download PDF
46. Non-Thermal Atmospheric Pressure Plasma Application in Endodontics.
- Author
-
Muniz AB, Vegian MRDC, Pereira Leite LD, da Silva DM, Moreira Milhan NV, Kostov KG, and Koga-Ito CY
- Abstract
The failure of endodontic treatment is frequently associated with the presence of remaining microorganisms, mainly due to the difficulty of eliminating the biofilm and the limitation of conventional irrigation solutions. Non-thermal atmospheric pressure plasma (NTPP) has been suggested for many applications in the medical field and can be applied directly to biological surfaces or indirectly through activated liquids. This literature review aims to evaluate the potential of NTPP application in Endodontics. A search in the databases Lilacs, Pubmed, and Ebsco was performed. Seventeen manuscripts published between 2007 and 2022 that followed our established inclusion criteria were found. The selected manuscripts evaluated the use of NTPP regarding its antimicrobial activity, in the direct exposure and indirect method, i.e., plasma-activated liquid. Of these, 15 used direct exposure. Different parameters, such as working gas and distance from the apparatus to the substrate, were evaluated in vitro and ex vivo. NTPP showed a disinfection property against important endodontic microorganisms, mainly Enterococcus faecalis and Candida albicans. The antimicrobial potential was dependent on plasma exposure time, with the highest antimicrobial effects over eight minutes of exposure. Interestingly, the association of NTPP and conventional antimicrobial solutions, in general, was shown to be more effective than both treatments separately. This association showed antimicrobial results with a short plasma exposure time, what could be interesting in clinical practice. However, considering the lack of standardization of the direct exposure parameters and few studies about plasma-activated liquids, more studies in the area for endodontic purposes are still required.
- Published
- 2023
- Full Text
- View/download PDF
47. Interfacing reduced graphene oxide with an adipose-derived extracellular matrix as a regulating milieu for neural tissue engineering.
- Author
-
Barroca N, da Silva DM, Pinto SC, Sousa JPM, Verstappen K, Klymov A, Fernández-San-Argimiro FJ, Madarieta I, Murua O, Olalde B, Papadimitriou L, Karali K, Mylonaki K, Stratakis E, Ranella A, and Marques PAAP
- Subjects
- Neurons, Extracellular Matrix chemistry, Tissue Engineering, Graphite chemistry
- Abstract
Enthralling evidence of the potential of graphene-based materials for neural tissue engineering is motivating the development of scaffolds using various structures related to graphene such as graphene oxide (GO) or its reduced form. Here, we investigated a strategy based on reduced graphene oxide (rGO) combined with a decellularized extracellular matrix from adipose tissue (adECM), which is still unexplored for neural repair and regeneration. Scaffolds containing up to 50 wt% rGO relative to adECM were prepared by thermally induced phase separation assisted by carbodiimide (EDC) crosslinking. Using partially reduced GO enables fine-tuning of the structural interaction between rGO and adECM. As the concentration of rGO increased, non-covalent bonding gradually prevailed over EDC-induced covalent conjugation with the adECM. Edge-to-edge aggregation of rGO favours adECM to act as a biomolecular physical crosslinker to rGO, leading to the softening of the scaffolds. The unique biochemistry of adECM allows neural stem cells to adhere and grow. Importantly, high rGO concentrations directly control cell fate by inducing the differentiation of both NE-4C cells and embryonic neural progenitor cells into neurons. Furthermore, primary astrocyte fate is also modulated as increasing rGO boosts the expression of reactivity markers while unaltering the expression of scar-forming ones., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2023
- Full Text
- View/download PDF
48. Extraction of hops pelletized (Humulus lupulus) with subcritical CO 2 and hydrodistillation: Chemical composition identification, kinetic model, and evaluation of antioxidant and antimicrobial activity.
- Author
-
Fischer B, Gevinski EV, da Silva DM, Júnior PAL, Bandiera VJ, Lohmann AM, Rigo D, Duarte PF, Franceschi E, Zandoná GP, Rombaldi CV, Cansian RL, Paroul N, and Junges A
- Subjects
- Antioxidants pharmacology, Carbon Dioxide, Humulus chemistry, Oils, Volatile pharmacology, Oils, Volatile chemistry, Sesquiterpenes
- Abstract
Hop essential oil and hop extract using carbon dioxide (CO
2 ) are products with high added value because they have bioactive and sensory properties. In this context, the objective of this study was to obtain and characterize essential oil and extracts from pelleted hops of El Dorado, Polaris, Hallertau Blanc and Callista varieties using hydrodistillation and subcritical CO2 extraction methods. Extraction yield ranged from 0.38 % to 1.97 % (m/m) for essential oils and from 8.76 % to 15.35 % (m/m) for extracts using subcritical CO2 . The chemical compositions of the essential oils were mainly monoterpene (18.14 % to 29.91 %) and sesquiterpene (46.01 % to 59.03 %) hydrocarbons and for the extracts were sesquiterpene hydrocarbons (33.05 % to 71.90 %) and oxygenated sesquiterpenes (14.80 % to 34.89 %). The extracts showed better antioxidant activity than essential oils due to the presence of phenolic compounds and flavonoids. Hop extracts showed some antimicrobial activity, but essential oils did not demonstrate antimicrobial potential. Hop extracts obtained with subCO2 have the potential to be used in the brewing industry as a flavoring and as natural antioxidants., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
49. Development and validation of LC-MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS-331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika.
- Author
-
Vilhena LS, de Azevedo da Silva AC, Dias da Silva DM, Pinto DP, Coelho EF, de Araújo JFGM, da Silveira GPE, Pereira HM, da Silva LSFV, Estrela Marins RCE, Bortolini RG, Souza TML, Dos Santos VGV, de Assis Nascimento V, Amendoeira FC, and da Fonseca LB
- Subjects
- Animals, Humans, Chromatography, Liquid methods, Limit of Detection, Plasma, Reproducibility of Results, Sofosbuvir, Tandem Mass Spectrometry methods, Zika Virus, Zika Virus Infection
- Abstract
Zika still poses a threat to global health owing to its association with serious neurological conditions and the absence of a vaccine and treatment. Sofosbuvir, an anti-hepatitis C drug, has shown anti-Zika effects in animal and cell models. Thus, this study aimed to develop and validate novel LC-MS/MS methods for the quantification of sofosbuvir and its major metabolite (GS-331007) in human plasma and cerebrospinal (CSF) and seminal fluid (SF), and apply the methods to a pilot clinical trial. The samples were prepared by liquid-liquid extraction and separated using isocratic mode on Gemini C
18 columns. Analytical detection was performed using a triple quadrupole mass spectrometer equipped with an electrospray ionization source. The validated ranges for sofosbuvir were 0.5-2,000 ng/mL (plasma) and 0.5-100 ng/mL (CSF and SF), while for the metabolite they were 2.0-2,000 ng/mL (plasma), 5.0-200 ng/mL (CSF) and 10-1,500 ng/mL (SF). The intra-day and inter-day accuracies (90.8-113.8%) and precisions (1.4-14.8%) were within the acceptance range. The developed methods fulfilled all validation parameters concerning selectivity, matrix effect, carryover, linearity, dilution integrity, precision, accuracy and stability, confirming the suitability of the method for the analysis of clinical samples., (© 2023 John Wiley & Sons Ltd.)- Published
- 2023
- Full Text
- View/download PDF
50. In vitro and in vivo applications of a universal and synthetic thermo-responsive drug delivery hydrogel platform.
- Author
-
Gholizadeh H, Landh E, Silva DM, Granata A, Traini D, Young P, Fathi A, Maleknia S, Abrams T, Dehghani F, and Xin Ong H
- Subjects
- Animals, Humans, Polyethylene Glycols chemistry, Drug Delivery Systems, Polymers chemistry, Hydrogels chemistry, Synthetic Drugs
- Abstract
A synthetic and thermo-responsive polymer, poly(N-isopropylacrylamide)-co-(polylactide/2-hydroxy methacrylate)-co-(oligo (ethylene glycol)), is used to formulate a universal carrier platform for sustained drug release. The enabling carrier, denoted as TP, is prepared by dissolving the polymer in an aqueous solution at a relatively neutral pH. A wide range of therapeutic moieties can be incorporated without the need for the addition of surfactants, organic solvents, and other reagents to the carrier system. The resulting solution is flowable through fine gauge needle, allowing accurate administration of TP to the target site. After injection, TP carrier undergoes a coil to globe phase transition to form a hydrogel matrix at the site. The benign nature of the polymer carrier and its physical gelation process are essential to preserve the biological activity of the encapsulated compounds while the adhesive hydrogel nature of the matrix allows sustained elusion and controlled delivery of the incorporated therapeutics. The TP carrier system has been shown to be non-toxic and elicits a minimal inflammatory response in multiple in vitro studies. These findings suggest the suitability of TP as an enabling carrier of therapeutics for localized and sustained drug delivery. To confirm this hypothesis, the capabilities of TP to encapsulate and effectively deliver multiple therapeutics of different physicochemical characteristics was evaluated. Specifically, a broad range of compounds were tested, including ciprofloxacin HCl, tumor necrosis factor-alpha (TNF-α), transforming growth factor beta 1 (TGF-β1), and recombinant human bone morphogenetic protein 2 (BMP2). In vitro studies confirmed that TP carrier is able to control the release of the encapsulated drugs over an extended period of time and mitigate their burst release regardless of the compounds' physiochemical properties for the majority of the loaded therapeutics. Importantly, in vitro and in vivo animal studies showed that the released drugs from the TP hydrogel matrix remained potent and bioactive, confirming the high potential of the TP polymer system as an enabling carrier., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.